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i 
Resumo 
 
 A Doença Pulmonar Obstrutiva Crónica é considerada pela Organização 
Mundial de Saúde um problema de saúde pública, afectando cerca de 270 milhões de 
pessoas em todo o Mundo. Em Portugal, o Observatório Nacional de Doenças 
Respiratórias (ONDR) estima que cerca de 540 mil portugueses sofram desta 
patologia, número que se encontra porém, subestimado, com muitos casos mal 
diagnosticados e outros ainda por diagnosticar. 
 A utilização da Oxigenoterapia Domiciliária de Longa Duração possibilita aos 
doentes reduzirem as consequências desta patologia, permitindo aliviar a pressão na 
artéria pulmonar e reduzir o esforço cardíaco. Neste tipo de tratamento, o oxigénio é 
utilizado por um período de tempo igual ou superior a 15 horas diárias, o que permite 
ao doente aumentar o seu nível da actividade física e melhorar substancialmente a 
sua qualidade de vida. Assim, estima-se que cerca de 2 milhões de pessoas em todo o 
mundo beneficiem deste tipo de terapia. 
 Actualmente, nos sistemas disponíveis no mercado, o controlo do débito de 
oxigénio é feito manualmente, o que leva, por um lado, a que o mesmo não coincida 
com as necessidades reais e dinâmicas do paciente, assim como a desperdícios de 
oxigénio, aumentando os custos associados à terapia. 
 A utilização de um sistema de controlo do débito em tempo real com base em 
leituras contínuas da saturação sanguínea de oxigénio permite, não só estabilizar de 
modo mais rápido e eficaz o doente, como também reduzir custos associados ao 
desperdício de oxigénio, assim como os gastos com o internamento hospitalar, 
provocados pelo estado continuado de dessaturação e as suas consequências 
negativas. Por outro lado, tendo em conta que a necessidade de oxigénio varia 
consoante o grau de actividade física do momento, os dados relativos ao mesmo são 
também relevantes no cálculo do volume de oxigénio a fornecer.    
 Esta tese fornece uma descrição da inclusão de uma válvula proporcional 
electrónica e respectivo hardware de actuação num sistema integrado, bem como do 
controlo dinâmico da abertura de saída, através de um microcontrolador, tendo por 
base dados de oximetria de pulso obtidos em tempo real. É igualmente apresentado 
um pequeno estudo realizado com o objectivo de implementar um controlador PID no 
dispositivo. 
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Abstract 
 
 Chronic Obstructive Pulmonary Disease (COPD) is considered by the World 
Health Organization a public health problem, affecting at least, 270 million people 
around the world. In Portugal, the ONDR estimates that more than 540 thousand 
people suffer from that pathology, a number which is certainly underestimated, 
considering the large number of unknown and under diagnosed cases. 
 The use of Long-Term Oxygen Therapy (LTOT) at home enables the patients to 
moderate the consequences of this condition, reducing the pressure in the pulmonary 
artery and the cardiac effort. In this type of treatment, the oxygen is used at least 15 
hours per day, allowing the patients to increase their level of physical activity and 
substantially improve their life’s quality. Thus, it is estimated that about 2 million people 
worldwide benefit from such therapy.  
Currently, in the systems available in the market, the control of the oxygen’s 
flow is done manually, which leads on the one hand, that it doesn’t match with the real 
and dynamic needs of the patient, and to the waste of oxygen, increasing the total 
costs of the therapy. 
The use of a flow control system in real time using continuous readings of blood 
oxygen saturation can, not only stabilize quickly and effectively the patient, but also 
reduce the costs associated with the waste of oxygen, as well as the internment’s 
spending in the hospital, caused by the continued state of desaturation and its negative 
consequences. Moreover, given that the need for oxygen varies with the degree of 
physical activity, the information on it is also relevant in the calculation of the oxygen’s 
volume to be supplied.  
This thesis provides a description of the inclusion of an electronic proportional 
valve and its hardware of actuation in an integrated system, as well as the dynamic 
control of the valve’s opening by means of a microcontroller, based on data from pulse 
oximetry obtained in real time. It also provides a brief description of a study done to 
implement a PID controller in the system. 
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1. Introduction 
 
1.1. Motivation 
 
Chronic Obstructive Pulmonary Disease (COPD) is an incurable and slow 
progress disease that results in air obstruction and breathing difficulties. In Portugal, 
more than 540 thousand people suffer from COPD, a number which is certainly higher, 
considering the large number of unknown and under diagnosed cases. Besides, the 
situation becomes worst in elderly people, since COPD frequency increases 
substantially with age. In fact, the Portuguese ONDR estimates that, above 60 years of 
age, the prevalence of the disease is 138 cases per 1.000 inhabitants in men and 62 
cases per 1.000 inhabitants in women. Furthermore, this disease is the sixth leading 
cause of death worldwide; the fifth in Europe and other developed countries, while in 
the U.S.A. is the fourth. 
Since this is a chronic disease, the patient lives with the illness, on average 20 
years, thus representing a burden for patients and for the state. In Portugal, the 
supplemental oxygen used in their treatment is fully reimbursed by the national health 
system. The treatments available to COPD relieve the pulmonary damage and slow the 
disease progression, consisting in the daily supplying with additional oxygen; this 
therapy is well known as Long Term Oxygen Therapy (LTOT). This treatment uses a 
constant and previously prescribed flow of oxygen, delivered from a gas cylinder, a 
liquid oxygen system or an oxygen concentrator for more than 15 daily hours. [1] 
However, oxygen levels vary with activity intensity and also with environment 
conditions, leading the patients both to hypoxia and oxygen’s wastage periods. Several 
studies demonstrated that, over the course of the patient’s daily activities, the arterial 
oxygen saturation falls below an acceptable threshold (SpO2<90%). However, 
excessive rates of oxygen also have negative consequences; in patients with 
hypercapnia, too much oxygen can depress ventilatory drive thereby aggravation of 
CO2 retention; increased levels of CO2 in the bloodstream can lead to acidosis. This 
indicates that patients aren’t realizing the full potential benefits of the oxygen therapy, 
because their oxygen’s demand isn’t well matched with the delivered flow.  
Additionally, we are in the era of the "Medicine of the Movement." The 
movement, especially walking on foot, is highly recommended to respiratory failure 
patients, since it is important, not only to the respiratory mechanics, but also to the 
improvement of respiratory physiology. However, the leg muscles are big consumers of 
oxygen and lead to large decreases in oxygen saturation, which creates discomfort. As 
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well, the physical activity is directly linked with the consumption of oxygen. Thus, for 
low levels of physical activity, the output flow needed is lower; while for higher levels of 
physical activity are required higher flows. So, this information is certainly relevant in 
the output flow determination. 
Furthermore, the oxygen delivery is controlled manually, but, special in acute ill 
patients, the achievement of safe and stable levels of oxygen saturation is not only 
difficult, but also time consuming, once it needs constant attention of the medical 
personnel.  
Previous studies attended in the automatic control of the supplemental oxygen 
deliver and demonstrated its potential in maintaining optimal blood oxygen saturation. 
The automatic control showed, therefore, to be more efficient in the patient 
management, especially in the systems that applied the pulse oximeter readings as 
feedback signal to a controller. [2] 
From an economic standpoint, the automatic control of the oxygen deliver 
generates the interest of multinationals that supply oxygen systems, which enables not 
only a significant saving of oxygen, but also resources’ savings. These companies 
have technicians who travel several times to the patients’ home to exchange the 
oxygen bottles; as this exchange is done in fixed periods of time, sometimes, are made 
unnecessary travel. Moreover, this area is also poorly explored.  
 
1.2. Objectives  
 
 The aim of this project is to build a system to automatically and efficiently 
control the deliver of oxygen to a chronic ill patient, by controlling the flow based on 
data collected in real time. As well, the proposed device intends to be a homecare 
solution to be used in home oxygen therapy. With a well known way of non-invasive 
monitoring technique- the pulse oximetry, it’s possible to access the oxygen saturation, 
observing the patient’s needs and also monitoring the treatment’s efficiency. By 
applying a 3-axis accelerometer in the system is possible to monitor the patient’s 
movement and therefore it‘s possible to control the oxygen flow by the movement. That 
represents a great advance for chronic ill patients that can have a dynamic therapy and 
consequently, they can improve their quality of life. With the projected system, the 
oxygen flow delivered from the source to the patient can be controlled dynamically and 
not statically, with a fix flow of oxygen, which is the major problem in the current 
available systems. Additionally, with the dynamic therapy it’s expectable to avoid the 
majority of the dessaturation periods and the discomfort caused by them.   
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1.3. Document Structure and Organization 
 
 This document is composed by 9 chapters; each one corresponding to different 
contends and blocks of work. 
This chapter is an introduction, with the project’s motivation and objectives. 
Chapter 2 describes the project management; its team members and the 
supervising at the different institutions that cooperated with this work. The chapter also 
refers the project planning. 
Chapter 3 is related to the theoretical background; it contains the mainly 
information achieved before the beginning of the system’s development. 
Chapter 4 is referred to the State of the Art; it’s a brief description of the projects 
in course that have the same goals as ours and also the works that use identical 
concepts. 
Chapter 5 describes the system development, providing its logic architecture 
and the project requirements and features. It also refers the miniature proportional 
valve and the driver board’s integration in the system and its actuation by the 
microcontroller, as well as the algorithm developed. 
Chapter 6 relates the effort done in order to implement a PID controller in the 
system. It refers not only the analytic development, but also the study in hospital’s 
ambience, where was collected data in the patients, which was latter analysed to 
calculate the PID parameters.  
Chapter 7 explains the prototype’s tests as well as their results; first in the 
laboratory and latter at the hospital, using medical oxygen and real saturation readings 
from the patients. 
Chapter 8 is a brief description of the future works to be developed to increase 
the functionality of the system. 
Chapter 9 is the conclusion, with a brief appreciation of the prototype obtained 
and its features. 
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2. Project Management 
 
2.1. Project Team Members 
 
 The project team was composed by two students of the integrated master 
degree in Biomedical Engineering from the Faculty of Sciences and Technology, 
University of Coimbra and the project coordinators from CEI (Centro de Electrónica e 
Instrumentação) of the Physics Department from the Faculty of Sciences and 
Technology of the University of Coimbra. It also counted with the technical supervising 
at ISA- Intelligent Sensing Anywhere, and at the Pneumology Service in CHC (Centro 
Hospitalar de Coimbra). The elements that composed the team work are presented in 
the next table. 
Name Contribute E-mail Contact 
Patrícia Borges Student pborges@isa.pt 
Neuza Aguiar Student naguiar@isa.pt 
Carlos Correia Coordinator correia@lei.fis.uc.pt 
José Basílio Simões Coordinator jbasilio@lei.fic.uc.pt 
Soraia Rocha Supervisor srocha@isa.pt 
José Luís Malaquias Supervisor jmalaquias@isa.pt 
Joaquim Moita Supervisor joaquimmoita@chc.min-saude.pt 
José Eduardo Faria Supervisor jfaria@isa.pt 
Table 1: Project team members, the students, the University coordinators, the ISA technical supervisors 
and the supervisor at CHC. 
 
2.2. Project Supervising 
 
The project supervising was divided between CEI, ISA and the Pneumology 
Service from CHC. 
 
2.2.1. Supervising at CEI 
The Electronics and Instrumentation Centre of the University of Coimbra 
develops work and research in different areas, such as nuclear, atomic and biomedical 
instrumentation, optical signal processing, instrumentation for plasma physics and 
telemetry and industrial control. The centre includes not only researchers and 
schoolmasters, but also technicians and students. The supervising at CEI consisted in 
a few informal meetings where was given to the student some documentation and also 
clarified some questions. 
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2.2.2. Supervising at ISA 
ISA, Intelligent Sensing Anywhere, was founded in 1990 by a group of 
engineers from the University of Coimbra, as a spin-off company. This company 
develops solutions in different areas, as remote management for utilities, including 
telemetry and remote metering solutions to different kinds of fuel, electricity and water, 
machine-to-machine solutions and, more recently, healthcare and medical solutions. 
At ISA, the work supervising was done in the first stage by Engineer José 
Eduardo Faria, as the technical supervisor. In the second stage, the supervision was 
conduced by Engineer Soraia Rocha, who became the project’s technical supervisor. 
During the supervising at ISA, the project also had the cooperation of Engineers José 
Luís Malaquias and Nuno Varelas.  
The supervising at ISA consisted of periodic meetings at ISA’s installations 
where were discussed not only the project evolution, but also the tasks and problems 
that the students were facing. Besides, the students always kept in contact with their 
technical supervisor to clarify doubts and questions that arose during the project. 
 
2.2.3. Supervising at Pneumology Service, CHC 
The supervising at the Pneumology Service from CHC consisted in several 
meetings with Doctor Joaquim Moita at CHC’s installations where were discussed 
some medical considerations that must be well thought-out during the building of a 
medical system. The cooperation of this service and particularly from Doctor Moita 
enabled the prototype’s tests in hospital’s ambience, as well as patient’s data collecting 
in some blocks of work. His guidance allowed the establishing of several features of the 
system and also the basis to the flow’s control algorithm. 
 
2.3. Project Planning 
 
The project was mainly divided in two functional areas, which were the pulse 
oximeter integration, its data acquisition and process, and the miniature proportional 
valve and the driver board’s integration and actuation by means of a microcontroller. 
Neuza Aguiar was responsible for the firmware development to the pulse 
oximeter integration, while Patrícia Borges was responsible for the firmware 
development to the proportional valve’s integration and actuation. The students 
cooperated to develop a global controller algorithm, where the oximeter data is 
received and according to it, the microcontroller actuates the valve. 
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In the first semester both of the students worked together in many tasks, 
especially in theoretical background area and in the system architecture, features and 
specifications definition. The students have also done some tasks, as the posters to the 
project’s presentations and also two presentations to ISA Intellicare staff, about the 
project and about the PIC microcontrollers programming. In the project’s first stage, the 
student was also focused in the system components, consequently there were made 
many contacts with companies that provide pulse oximeters and miniature proportional 
valves. 
In the second semester, there were a division of work between Patrícia and 
Neuza. Each student followed a plan of tasks given by the project technical supervisor, 
which was focused in each functional area. Furthermore, the student has also done a 
few studies in order to implement a PID controller in the system, including the data 
collecting at the Urgency Service of CHC. 
Following the algorithm’s development by each student, they built a global 
algorithm to control the integrated system and they have done some computer tests. 
With those tests, they proceeded with the optimizations in each algorithm’s part. 
The last stage of the project was done together again and consisted in the 
prototype’s experiments that were done at the Pneumology Service. Those tests 
enabled the analysis of the system’s behaviour in real conditions, since they were done 
in a patient and with medical oxygen. 
 
2.4. Gantt Charts 
 
There are shown next the project’s Gantt charts with the mainly tasks of the 
project, as well as their planning and the resources used. The colours’ scheme applied 
to represent the resources used in the tasks is the follow: 
 
 
 
 
 
 
 
 
 
 
Task done by Patrícia Borges 
 
Task done by both students 
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Figure 1: Gantt charts from the 1st stage of the Project. 
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Figure 2: Gantt chart from the 2nd stage of the Project. 
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3. Theoretical Background  
3.1. The Respiratory System 
The respiratory system is composed by two parts, the upper respiratory system 
and the lower respiratory system. The upper part is composed by the nose, nasal 
cavity, paranasal sinuses and pharynx. These passageways are responsible for the 
filtration, warming and humidification of the air, protecting the surfaces of the lower 
respiratory system. On the other hand, the lower respiratory system consists of the 
larynx, trachea, bronchi, bronchioles and alveoli of the lungs, where the gas exchanges 
occur. [3] 
 
Figure 3: Diagram of the Respiratory System, showing its components and a diagram of the alveoli 
(bronchiole’s terminals) with the capillaries to the gas exchanges. [4] 
 
 This system is responsible for five major functions: providing gas exchanges 
between air and circulating blood; moving air to and from the respiratory surfaces of the 
lungs; protecting respiratory surfaces from dehydration, temperature changes and 
environmental variations; production of sounds used in oral speaking and providing 
olfactory sensations to the central nervous system from the olfactory epithelium in the 
superior part of the nasal cavity.  
 The respiratory system is controlled by the brain’s respiratory centres, which are 
coordinated with changes in cardiovascular system, fluctuations in blood pressure and 
cardiac output. The cerebral centres are responsible for the regulation of the 
respiratory muscles’ activity, such as the diaphragm and the external intercostal 
muscles, by the generation of impulses, and they also control the respiratory minute 
    
 
 
11 
volume by adjusting the frequency and depth of pulmonary ventilation. The motor 
neurons in the spinal cord, which are generally actuated by respiratory reflexes, can 
also control the respiratory muscles. [4]  
3.2. Respiratory Failure 
 Respiratory failure is characterized by the inability of the lungs to adequately 
exchange oxygen and carbon dioxide between the environment and the body tissues, 
transferring oxygen from inhaled air into the blood and carbon dioxide from the blood 
into exhaled air. [5] The direct consequence of this situation is the inability to keep the 
arterial blood gases at normal level, leading to PaCO2>49 mmHg and/or PaO2<60 
mmHg, in room air (0.21 FiO2). [6] 
The basis of respiratory failure may be at several points; it may be a failure of 
the exchange of oxygen and carbon dioxide within the alveoli in the lungs; a failure of 
respiratory muscles to expand the lungs; or a failure in brain centres controlling 
respiration. [5] 
The respiratory failure can be either chronic or acute and it’s classified as 
hypoxemic or hypercapnic. In hypoxemic respiratory failure there are low levels of 
PaO2, which is lesser than 60 mmHg, while the PaCO2 is at normal or low levels. In 
hypercapnic respiratory failure the PaCO2 is greater than 50 mmHg and hypoxemia is 
also common on hypercapnic patients while they’re breathing ambient air. Chronic 
respiratory failure is developed over several days or even longer time periods, while 
acute respiratory failure is developed during periods ranging from minutes to hours. [7] 
Chronic Obstructive Pulmonary Disease (COPD) is a term used to describe two 
related lung diseases: Chronic Bronchitis and Pulmonary Emphysema. Chronic 
bronchitis is an inflammation and eventual scarring of the bronchi, while Emphysema is 
an enlargement and destruction of the alveoli within the lungs. Patients with COPD 
may suffer from both of these problems, leading them to breathing difficulty because of 
the smaller air passageways, which are also congested with mucus and also to partially 
destroyed alveoli. The most important risk factor, which is also COPD cause, is 
smoking, in fact, about 80 to 90% of COPD cases are caused by smoking and a 
smoker is much more probable than a non-smoker to suffer/die of COPD. [8] 
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Figure 4: Chronic Bronchitis and Pulmonary Emphysema: comparison between healthy bronchi, 
bronchiole and alveoli with Chronic Bronchitis and Pulmonary Emphysema ones. [8] 
3.3. Oxygen Therapy 
The goal of therapy in respiratory failure is to achieve and maintain adequate 
gas exchanges. [6] The oxygen therapy consists of oxygen’s administration in higher 
concentrations than in ambient air to reduce the effects caused by the oxygen’s lack. 
[9] Furthermore, the treatment with supplemental oxygen is commonly used to improve 
quality of life, reliving hypoxemia, which raises the alveolar tension, reduces the 
breathing’s work and decreases the myocardium’s effort. [6] Thus leads to an 
increasing of exercise tolerance, energy and level of activity, which is fundamental to 
keep healthy. [9]  
Treatment of patients with oxygen at home is called either Home Oxygen 
Therapy or Domiciliary Oxygen. [10] Oxygen Therapy can be prescribed in two different 
ways: short and long term. Short term oxygen therapy is applied when the patient is 
recovering from acute lung disorders, like pneumonia, that causes low levels of 
oxygen. On the other hand, in long term oxygen therapy (LTOT) the patient receives at 
least 15 hours per day of oxygen to achieve the maximum benefits of the treatment. [9] 
LTOT has several benefits, such as increases survival, reduces pulmonary artery 
pressure, alleviates right heart failure, neuropsychological improvement, and also the 
improvement of sleep quality and the reduction in cardiac arrhythmias. [11]  
Non-continuous oxygen therapy is usually prescribed to alleviate or diminish 
pulmonary symptoms in particularly situations, such as the sleeping hours. Nocturnal 
oxygen is only applied during sleep due to the desaturations that occur in this period. 
[10] 
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Figure 5: Terminology of Home Oxygen Therapy. [10] 
 
3.4. Oxygen delivery systems  
 There are three oxygen sources available for LTOT at home: oxygen 
concentrators, liquid oxygen systems (LOX) and high-pressure cylinders, filled with 
gaseous oxygen. [12] The oxygen is administrated through oronasal devices, such as 
nasal cannulae and catheters and different kinds of face masks, like Venturi mask. [6] 
 
3.4.1. Oxygen Concentrators 
 Air is mainly composed by nitrogen, about 78%, oxygen at 21% and other 
gases, such as argon and carbon dioxide, in a small amount, 1%. [13] 
 An Oxygen Concentrator is an electric device that separates oxygen from other 
gases in atmospheric air, through the employment of a molecular sieve. [14] Thus, 
allows the continuous delivering of concentrated oxygen to the patient and takes away 
the obligation of changing the oxygen’s cylinders.  
The atmospheric air is drawn into the unit through a series of particle filters; it’s 
compressed, into a compressor, and then passes through a heat exchanger to 
dissipate the heat of compression. [12] Then, it passes through a cylindrical molecular 
sieve bed, the “zeolite tower”, filled with a zeolite material, aluminium silicate. The 
nitrogen molecules are captured and selectively adsorbed onto the zeolite granules, a 
reversible reaction. When the zeolite granules become saturated with nitrogen, the 
system changes to a second tower through a switch valve, to achieve a constant 
production of oxygen. In the meanwhile, the first tower is vented off to ambient 
atmospheric pressure and the adsorbed nitrogen is released from the granules, which 
become capable of adsorbing nitrogen again. [15] The system stores the concentrated 
oxygen in a small cylinder for delivery to a flow meter. [12] 
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Figure 6: Diagram representing a molecular sieve oxygen concentrator. [12]  
 
With an oxygen concentrator, the oxygen is delivered in high concentrations, 
although they don’t get a purity of 100%. The Fraction of Inspired Oxygen (FiO2) will 
depend on the flow rate; with lower flow rates the oxygen’s concentrations are higher. 
[12] The produced oxygen’s purity is presented in the next table. 
 
Flow Rate Oxygen’s Concentration 
≤1 L/min FiO2≤0.97 
1-2 L/min FiO2≥0.95 
3-5  L/min FiO2≥0.90 
>5 L/min FiO2<0.90 
 
Table 2: The Output of oxygen concentrators, the correlation between the oxygen flow rate and the 
oxygen’s purity (FiO2). [12], [14] 
 
3.4.2. Liquid Oxygen Systems 
 Liquid Oxygen (LOX) Systems store large amounts of oxygen in small and 
compact containers at low pressure, as in the liquid form 1L of LOX is equal to 840 L of 
gaseous oxygen. [12] The system is usually composed by two units: a stationary 
reservoir and a lightweight portable unit. When the patient is at home uses the 
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stationary source as the primary source and, when leaves home, fills the smaller 
portable unit. [16] Both the stationary and the portable units are constructed as a 
thermos bottle, with an inner and outer container with vacuum between them, keeping 
the oxygen at -297.3ºF and under a pressure of approximately 20 psi. [12], [17] 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: LOX containers, showing several stationary units and also a portable one. [18] 
 
In the lower portion of the container, the oxygen is in the liquid form, while in the 
upper portion it’s in the gaseous form, due to the evaporation. The flow control valve 
deliveries oxygen and it’s opened when the unit it’s being used by the patient. This 
creates a pressure gradient between the oxygen in the upper portion of the container, 
which is the head pressure, and the atmospheric pressure. LOX them passes through 
the vaporizing and warming coils where it is converted into gas available to the 
patient’s use. When the head pressure falls below a certain limit, LOX is collected from 
the container’s base to guarantee a constant flow to the patient. The LOX is under 
pressure and the ambience temperature causes evaporation of the liquid to gas, 
creating more pressure in the reservoir. In a certain pressure point, a primary relief 
valve opens to vent to the outside.  
The container also has a secondary relief valve that opens when the pressure 
reaches 10 psig above the working pressure, if the primary valve fails. [17] The quick 
connect attachment is the connection to fill the portable unit. [12] 
The major advantage of LOX systems is not only the large quantity stored, but 
also its purity; it contains 100% oxygen in a small and even portable unit. However, 
LOX systems are very expensive, since they have two reservoirs and the stationary 
reservoir must be filled by a technician every 10-14 days, which raises the costs. In 
addition, the transfilling of LOX from the stationary reservoir to the portable unit is 
complex and can cause thermal burns in the skin due to the low temperatures, if the 
patient touches the LOX. [12] 
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Figure 8: Components of a stationary LOX container. [12] 
 
3.4.3. Oxygen Cylinders 
 Oxygen cylinders are made of steel or aluminium and they’re filled with 
compressed gaseous oxygen under high pressure. [19] They’re available in a wide 
variety of sizes, ranging from large stationary to small portable ones. [9] Each company 
has developed alternative sizes of small portable cylinders. Usually, the portable 
cylinders, also called ambulatory oxygen, are made in aluminium which can have less 
50% of the weight when compared with similar ones in steel. [12] 
The cylinder’s dimension is identified alphabetically from A, which is the 
smallest one, to E, which is the bigger one. H and G cylinders are fixed and the others 
are portable. The major limitation of this oxygen delivery system is the limitation of the 
gas volume. [12] In the next table is presented the duration of the each cylinder at 2 
L/min of flow: 
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Size Litres (L) Time 
H 6908 57h, 33 min 
G 5302 44h, 11 min 
M 3625 30h, 12 min 
E 616 5h, 8 min 
D 352 2h, 56 min 
B 150 1h, 15 min 
A 76 38 min 
Table 3: Oxygen Cylinders size, storing capacity and time duration (at 2L/min). [12]  
 
Figure 9: Various types of high pressure cylinders used in medical gas therapy. [20]  
 
The portable oxygen is prescribed to patients in LTOT to allow their mobility and 
let them leave home on a regular basis. To be portable, the system must be 
lightweight, compact and also capable of providing oxygen for extended periods. [9]  
The portable oxygen system consists of a pressurize cylinder/tank, with an 
on/off valve, a pressure gauge and a flow regulator knob. [21] The Regulator is 
attached to the top of the tank and is responsible for the oxygen flow control and also 
for the reducing of the oxygen’s pressure to a level that can be safety used by the 
patient, which is known as the working pressure. [22] It consists of two gauges, one is 
the pressure gauge that indicates and registers the amount of oxygen that is in the 
cylinder and the other one is a flowmeter that shows how much oxygen is flowing from 
the cylinder to the patient and it’s marked in lpm. [23] The regulator has attached a flow 
regulator knob to adjust the liter flow; it determines the rate of oxygen that leaves the 
tank and goes to the patient. [24] 
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Figure 10: Schematic representation of an Oxygen Delivery System constituted by an oxygen cylinder 
and associated setup: on/ off valve, a pressure gauge and flow regulator knob. [25] 
 
 Commonly, the cylinder’s valve is opened either with a special wrench or with a 
handle. As well, the valve has two holes for alignment with the two pins on the 
oxygen’s regulator, which is called the Pin Index System. [26]  
 
Figure 11: Schematic representation of an Oxygen Delivery System showing the pin index system used 
to attach the regulator to the oxygen tank; the pins for alignment in the regulator match with the holes of 
the valve. [25] 
 
The Pin Index System’s goal is to prevent accidents, ensuring that a medical 
oxygen tank only receives a regulator for medical oxygen and certifying that only 
medicinal oxygen is administered to patients in oxygen therapy.  
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The system consists of a series of protruding pins in the regulator that are in 
configuration with the associated cylinder outlets, which has a series of pin inlets. 
These inlets will only allow the regulator designed for that tank to be fitted properly. [24] 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Pin Index System, showing the outlet pins in the regulator and the correspondent inlet pins in 
the cylinder. The regulator has several pins which are used for specific types of gases. [20] 
 
3.5. Patient Interfaces 
To the oxygen’s administration can be use several patient interfaces, each one 
with a different purpose. [16] In the next table there are shown some of these devices, 
as well as the flow and FiO2 provided and also the appropriate instance of use. 
 
Device Flow (lpm) FiO2 (%) Appropriate Use 
Nasal Cannula ¼ -8 22-45% LTOT patients 
Transtracheal 
Catheter 
¼-4 22-45% Patients who don’t accept cannula, high 
flow needs 
Reservoir Cannula ¼-4 22-35% LTOT patients 
Simple Mask 6-12 35-60% Acute short-term therapy requiring 
moderate FiO2 
Reservoir Mask 6-10 35-60% Emergencies, acute hypoxemia, 
moderate FiO2 
Nonrebreather Mask 10-15 80-100% Emergencies, Respiratory failure 
Table 4: Types of patient interfaces, the correspondent flow and FiO2 provided and also the appropriated 
instance of use. [16] 
 
The patient interface can be classified either in low or high flow device. In Low 
Flow devices, the oxygen flow provided doesn’t match the entire patient’s flow needs; 
therefore, the oxygen given to the patient is mixed with room air. The oxygen’s 
concentration can be either high or low. High Flow devices provide a fixed gas mixture, 
which meet or even exceed the patient’s requirements. The low flow devices are the 
nasal cannula, the nasal and transtracheal catheters, the simple face mask and the 
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partial rebreather mask, while the high flow devices are the non- rebreather mask, the 
Venturi mask and the aerosol systems. [27], [28] 
The Nasal Cannula is frequently used in home oxygen therapy due to its 
simplicity and patient convenience. It is composed by two thin plastic tubes, the nasal 
prongs, which are inserted into the patient’s nostrils, providing the entrance of the air. 
[29] When the delivered flow is higher than 4 lpm it’s recommended a humidifiers’ use 
to reduce the patient’s discomfort and dehydration of the nasal passages. [27], [28] 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Nasal Cannula, with two nasal prongs insert in the patient’s nostrils. [30] 
 
The Nasal Catheter is rarely used nowadays; it’s uncomfortable and has been 
replaced by the nasal cannula. [30] It has small holes at the tips which are lubricated 
with liquid paraffin, to avoid nasal passage trauma, and it’s inserted through the nostrils 
to the oropharynx and is placed behind the uvula. [6] The nasopharynx and the 
oropharynx act as natural reservoirs, which increase the device’s efficiency, 
nevertheless the nasal catheter can cause gastric distension or even rupture if the 
catheter is pushed in to far. [31] This device is used to deliver low flows of oxygen, 
ranging from 0.25-8 lpm with a concentration of 22 to 45%. [30] 
 
Figure 14: Nasal Catheter with the tip located behind the patient’s uvula. [30] 
 
The Simple Mask is a face piece that covers the patient’s mouth and nose; it 
has a central port to provide the oxygen’s entry through the oxygen inlet connection. 
The gases are then exhausted through the exhalation ports at the sides of the 
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mask.[31], [32] The final FiO2 is dependent of the amount of room air that mixes with 
the oxygen into the mask, which varies with the patient’s respiratory pattern, changing 
with the peak inspiratory flow rate and also with the respiratory rate. [29], [31] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Simple mask, with the lateral exhalation ports and the oxygen inlet to the oxygen’s entry. [30] 
 
The Partial Rebreathing Mask is similar to the simple face mask, but it has in 
addition a reservoir bag to collect oxygen during the expiration. This mask’s purpose is 
to conserve oxygen, since some of the exhaled air is rebreathe, reducing the wastes. 
On the other hand, it can lead to hyperoxygenation, particularly in COPD patients and 
also dehydration when used with high flows or even eye irritation, with the mask’s 
wrong placement. [32] The FiO2 achieved is about 0.70 and the flow varies from 6-10 
lpm. [31] 
The Non-Rebreathe Mask has a reservoir bag attached and uses one-way 
valves on the exhalation port and between the reservoir bag and the mask to deliver 
the highest possible oxygen’s concentration. [31] The attached reservoir bag fills with 
oxygen between breaths and the valves prevent the inhalation of room or exhaled air 
through the exhalation ports. [29] The difference between this mask and a partial-
rebreather mask is the placement of a one-way valve between the reservoir bag and 
the mask. [32] This valve prevents the entrance of the exhaled gases in the reservoir 
bag during the expiration. [31] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Non-Rebreathe Mask with and without the valves placed. [30] 
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The Venturi Masks are high flow systems that delivery a fixed FiO2 to the 
patient using the Venturi Effect as mechanism of actuation. The predetermined 
concentration of oxygen is delivered into the mask through a jet orifice which is narrow. 
Because of the high velocity of the oxygen flow and the narrow orifice into the Venturi 
barrel, there’s a progressive reducing of the pressure throughout the constricted 
section. It results in a negative pressure that pulls the room air into the mask through 
the air entrainment ports. The expired gas is then exhausted through the exhalation 
holes on the mask to reduce to minimal its rebreathing. The Venturi mask can deliver 
flows ranging from 6-10 lpm with oxygen’s concentration varying from 24 to 44%. [31], 
[32] 
 
 
 
 
 
 
 
 
 
Figure 17: Venturi Mask, with the jet orifice to the oxygen delivery and the air entrainment port to the 
room air admission. [30] 
 
3.6. Oxygen Conserving Devices 
 Oxygen conserving devices allow the oxygen’s saving, substantially extending 
the duration of liquid portable or small high-pressure gas systems, making easier the 
patient’s ambling outside home. [33] There are currently available three methods of 
oxygen’s conservation: Transtracheal Oxygen Catheters (TOC), Reservoir Systems 
and Demand Oxygen Delivery Systems (DODS). [34] 
 
3.6.1. Transtracheal Oxygen Catheter 
 TOC are plastic tubes, small and flexible insert directly into the trachea to 
release oxygen. Oxygen flow rates can be reduced in 50% at rest and 30% during 
exercise, when compared with oxygen delivered by nasal cannulae and for the same 
SaO2. [35] TOC has low flow requirements since the anatomical dead space acts like a 
reservoir, leading to oxygen’s conserving. As well, the aesthetics question is also 
improved and also the taste and smell; in addition, it reduces the soreness that 
commonly occurs in the face caused by nasal cannulae. [36]  
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Figure 18: Diagram of the transtracheal catheter positioning and a picture of two TOC. [37] 
 
3.6.2. Reservoir Systems 
Reservoir systems have an additional reservoir near the airway, in general with 
a capacity of 20 mL to conserve the oxygen delivered during the exhalation, which 
reduces the required flow rate and saves a significant amount of oxygen. [36] The 
oxygen conserved is delivered during the next inhalation as a bolus. [38] The reservoir 
can be either moustache or pendant type; the moustache type has the reservoir under 
the patient’s nose, while the pendant type is suspended in the front of the patient’s 
chest. [36]  
 
 
 
 
 
  
 
 
 
 
Figure 19: A pendant type reservoir system, the oxygen is stored in the reservoir during the exhalation 
and rebreathe in the next inhalation. [39] 
 
 
The reservoir cannula is a moustache type system; it has a small reservoir to 
collect oxygen during the exhalation to deliver in the inhalation, thus saving oxygen that 
would be waste to the atmosphere. [34] In Oxymizer reservoir nasal cannula (Chad 
Therapeutics, USA), the gas saved during the exhalation is then inhaled at the 
beginning of the next inhalation, due to the presence of a membrane that creates a 
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capture chamber. In the exhalation, the membrane is pushed forward to create a 
capture chamber for oxygen, while in the inhalation the membrane collapses to deliver 
the collected oxygen. [38] 
(a) (b) 
Figure 20: The Oxymizer reservoir nasal cannula, during (a) the exhalation and (b) the inhalation. [38] 
 
Reservoir systems are simple, safe and efficient, although the moustache type 
isn’t aesthetics agreeable to the patient that commonly uses it only at home. The 
pendant type is less perceptible, so it is used outside home more regularly. [36] It has 
the incontinent of the weight that can cause discomfort in the user’s ears loop. Both of 
the devices work as standard nasal cannulae. [38]    
 
3.6.3. Demand Oxygen Delivery Systems 
 DODS are conserving systems since they sense the beginning of a breath, 
which opens the valve, and only deliver oxygen during the inhalation, interrupting the 
flow during the exhalation, when it would be wasted. [40] These devices are of three 
types: pulse, demand or hybrid and the difference between each other is in the way 
how oxygen is delivered. In pulse devices, the oxygen is only provided in the initial part 
of the inhalation as a bolus of gas, but in higher flow rates than in continuous flow. The 
demand devices provide a bolus of oxygen at the beginning of the inhalation and 
maintain a continuous and smaller flow during the entire inhalation, so the flow rate 
needed is less than for the pulse devices. [36], [40] The hybrid device joins the 
operational principles from both of pulse and demand devices, providing an early bolus 
in the onset of the inhalation, followed by a continuous flow. [41] 
 DODS can be classified as electronic or pneumatic/mechanical according to the 
technique that they use to open the valve. Pneumatic conservers use the gas pressure 
to actuate the valve and they don’t require electric power. Electronic conservers are 
battery powered and use the time predetermined by the manufacturer to open the 
valve. [36] 
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Figure 21: Intermittent-flow oxygen-conserving devices. Front row (left to right): EX-3000 (DeVilbiss, 
Somerset, Pennsylvania), EX-2000 (DeVilbiss), Impulse Select (AirSep, Buffalo, New York), CR-50 
(Mallinckrodt, St Louis, Missouri) OxiClip (Mallinckrodt). Back row (left to right): O2N Demand (Victor, 
Denton, Texas), O2 Advantage (Western Medica, Westlake, Ohio), Venture (Invacare, Elyria, Ohio), DOC-
2000 (Transtracheal Systems, Englewood, Colorado), Oxymatic 301 (Chad Therapeutics, Chatsworth, 
California). [36] 
 
 Although oxygen conserving devices enable significant oxygen’s savings, not all 
the patients accept these apparatus; when they pass from continuous flow oxygen 
therapy to an intermittent flow oxygen therapy, some patients do not become 
accustomed and fell like they’re not receiving enough oxygen, which causes them 
discomfort. 
 
 
3.7. Oxygen Dosing 
 Commonly, when it’s used the oxygen delivery with continuous flow, the dosing 
prescribed is 2 lpm through nasal cannula. This fixed amount results from two studies 
made in the 60’s, one in Winnipeg, Canada, and another one in Denver, USA. In both 
of them, there was analysed a small amount of COPD hospitalized patients whose 
oxygen flow rate was increased gradually, under state stable conditions. Both of them 
demonstrated that the COPD patients can be managed with a fixed flow of 2 lpm. So, 
the Nocturnal Oxygen Therapy Trial (NOTT) established for patients with COPD and 
hypoxemia the oxygen delivering of 1 to 2 lpm by nasal cannula and during sleep and 
exercise the flow is increased 1 litre, from 2 lpm to 3 lpm, due to the common the 
desaturation that occurs in the sleep hours, specially in the REM phase of sleep. [42] 
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3.8. Pulse Oximetry 
Pulse oximetry applies the optical properties of blood to continuously and non-
invasively monitor the level of oxygen in the blood stream and the heart rate. The pulse 
oximeter has a pair of LED’s that operate at two different wavelengths: one is a red 
LED with a wavelength of 660 nm and the other is a near infrared LED with a 
wavelength of 910 nm. Both of the LED’s are placed in the opposite way of a 
photodiode, an optical sensor that detects the emitted light from each LED. The sensor 
is placed either in the finger or in the ear. [43] 
 
Figure 22: Representation of a typical pulse oximeter, the two LED’s, red and near infrared, emit light 
that passes through the patient’s finger and is then collected by the photodiode. [43] 
 
This technique is based in the blood’s colour change due to the variable 
quantity of light absorbed by the haemoglobin, which depends on its saturation with 
oxygen. When the haemoglobin is oxygenated, constituting the oxyhaemoglobin, it 
doesn’t absorb large quantities of red light, but when haemoglobin oxygen’s saturation 
falls, this quantity increases, turning the blood darker. On the other hand, the near 
infrared light is more absorbed by oxyhaemoglobin than by haemoglobin. [44] 
Accordingly, the absorption coefficients are different for the two types of haemoglobin 
and also vary with the light wavelength, as represented in the next figure: 
 
 Figure 23: Absorption coefficient for the two types of haemoglobin for each LED’s wavelength; the red 
light (660 nm) is more absorbed by the haemoglobin and the near infrared light (910 nm) is more absorbed 
by the oxyhaemoglobin. [43] 
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The blood oxygen saturation, SpO2, is calculated based on Beer-Lambert law, 
which uses the relation between the concentration of a solute and the intensity of light 
transmitted through a solution at a specific wavelength. According to this law, the 
concentration of a solute in a solvent is determined by the amount of light that is 
absorbed by the solute at a specific wavelength; as oxyhaemoglobin and 
deoxyhaemoglobin preferentially absorb one of the two wavelengths of light used, their 
concentrations can be simply determinated. [44] Thus, SpO2 is defined as the ratio of 
oxyhaemoglobin to the total concentration of haemoglobin, as represented in the 
equation below:  
[ ]
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Equation 1: The blood oxygen saturation, SpO2, is given by the ration between the concentrations of 
oxyhaemoglobin and the total of haemoglobin. 
 
The pulsatile change in light transmission is caused by variations in arterial 
blood volume between the source and the light detector and represents the blood 
pulsing in the arteries. The blood pressure varies in the heart cycle and the amount of 
blood in the capillaries depends directly on it; so the heart rate can also be measured 
through this method. Hence, this technique is a combination of two technologies of 
spectrophotometry, which are responsible for the blood oxygen saturation 
measurement and optical plethysmography, which measures the pulsatile changes in 
arterial blood volume at the sensor placement. [44] 
 
3.9. Electronic Proportional Valve 
An electronic proportional valve is a mechanical device electromagnetically-
operated that is commonly used in closed-loop systems to control the flow or pressure 
rate. It’s a type of solenoid valve; however in solenoid valves the electrical current is 
just switched on/off while in proportional valves the current is regulated to accurately 
control the output flow/pressure. These equipments are termed proportional since the 
output flow/pressure isn’t exactly linear in relation to the input current. [45], [46] 
The proportional valve is composed by two main parts: the solenoid and the 
valve. The solenoid is a coil of wire that becomes magnetized when electricity is run 
through it and it’s responsible for electrical energy’s conversion into mechanical 
energy, which opens and closes the valve mechanically. The valve also has a spring, 
which is an elastic object that stores mechanical energy and is commonly made of 
hardened steel. It is responsible for maintaining the valve either opened or closed while 
    
 
 
28 
it isn’t activated. The valve has at least two ports, one inlet and one outlet port, to the 
inlet and outlet flow, but it can also have three or even more ports.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Solenoid Valve, normally closed type, and its components. [47] 
 
The valve’s principal of operation is the balanced between two proportionally 
and opposite forces acting on the plunger: the mechanical force provided by the spring 
and the magnetic force, created by the electrical current passing through the solenoid. 
The electrical current flowing through the coil creates a magnetic field which is 
proportional to the current applied. Therefore, the force produced by the solenoid 
results from strength of the magnetic field, which forces the plunger down. The 
mechanic force applied by the spring forces the plunger up. As the input current varies, 
the output opening varies as well, resulting in a wide variety of output diameters. So, by 
varying the current in the solenoid, the amount of coil movement can be varied and 
hence the amount of flow through the valve can be controlled. [45], [47] 
The valve can be either normally closed or normally open. In normally closed 
valves, they open when the coil is magnetized and re-close when the current is 
removed from the coil. In normally open valves, when the current flows through the coil, 
it becomes energized, closing the valve. When there isn’t applied any electrical power 
the valve is therefore opened. [47] 
The valve can be controlled by varying the voltage as well as the electrical 
current to the solenoid. However, varying the voltage it isn’t as accurate as varying the 
current, since at a certain voltage the correspondent current increases the resistance of 
the coil by temperature rise. The current determines the magnetic force that opens the 
valve, so at the end, the flow through the valve may be reduced because the valve will 
tend to slowly close after a while when the control is done by voltage varying. The 
deviation is about 4% in voltage control versus current control. [48] 
 
1. Valve body 
2. Inlet port 
3. Outlet port 
4. Coil/Solenoid 
5. Coil windings 
6. Lead wires 
7. Plunger 
8. Spring 
9. Orifice 
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3.10. Proportional, Integral, Derivative Controller 
The Proportional, Integral, Derivative (PID) control is extensively used in 
systems that involve automatic management. Its structures may be modified, but its 
bases remain the same. PID algorithm principle’s is the feedback control; it has the 
ability to control the output of a process variable, approaching and maintaining it from a 
desired value, the setpoint. The PID controller measures the process variable and 
compares it to the setpoint. According to the control error, the PID controller calculates 
the correction to be applied in the control device, which changes the process input. 
Those corrections will allow the process to become equal or within the range of the 
setpoint. Therefore, the PID algorithm involves three different terms, the Proportional, 
the Integral and the Derivative term, each one with a specific purpose. [49] The 
algorithm’s is described by follow equation:  
))()(1)(()(
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Equation 2: PID algorithm’s equation, where u(t) is the control signal, e(t) is the control error, Kp is the 
proportional gain, Ti is the integral time and TD is the derivative time. 
dt
tdeKdeKteKtu D
t
iP
)()()()(
0
++= ∫ ττ  
Equation 3: PID algorithm’s equation, where u(t) is the control signal, e(t) is the control error, Kp is the 
proportional gain, Ki is the integral gain and KD is the derivative gain. 
 
Where: 
i
P
i T
KK =   Equation 4 
DPD TKK ×=  Equation 5 
 
 u(t) is the control signal and e(t) is the control error, given by the difference 
between the setpoint and the measured value. If the measured variable is y and the 
setpoint is ysp, the error is: 
yyte sp −=)(  
Equation 6: Control error, e(t), where y is the measured variable and ysp is the setpoint. 
 
 The control signal is therefore the sum of three terms, the P-term that is 
proportional to the error, the I-term that is proportional to the integral of the error and 
the D-term that is proportional to the derivative of the error. K, Ti and Td are the 
controller parameters, which are the proportional gain, the integral time and the 
derivative time, correspondingly. Those three terms can be view as the past, present 
and future contributions to the controller. [50] 
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Figure 25: Schematic representation of a PID controller. [51] 
 
The PID controller can be used on a microcontroller, which allows the automatic 
tuning, the gain scheduling and also a continuous adaption. [50] 
3.10.1. Proportional Term 
The proportional term, also called gain, directly reacts to a non-zero control 
error to make smaller its contribution to the measured process variable. This term is 
given by the equation: 
)(teKP P=  
Equation 7: Proportional term from the PID controller, where P is the proportional term of the output, KP 
is the proportional gain and e(t) is the  control error. 
 
The effect of this term is always prevailing when the control error is large and is 
reduced when the error approaches to zero. [49] 
A high KP leads to a large change in the output for a certain change in the error, 
but for KP values too high, the system’s response can become unstable since the 
tendency to oscillate is increased. Nevertheless, small gains result in small changes in 
the output response due to a large input error, which results in a less sensitive 
controller to system disturbances. [49], [51] 
3.10.2. Integral Term 
The integral term, also called reset, progressively removes the control error, 
correcting the offset and the strength of this term is increased with decreasing integral 
times (Ti). [49] It is proportional to both of the error and its duration. [51] This term is 
given by the equation: 
∫=
t
i deKI
0
)( ττ  
Equation 8: Integral term from the PID controller, where I is the integral term of output, Ki is the integral 
parameter and e(τ) is the  control error. 
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The integral control increases the movement of the process towards the 
setpoint, but, since the integral term responds to the past’s accumulated errors, the 
present value can overshoot the setpoint, crossing it in other direction. [51] 
 
3.10.3. Derivative Term 
The derivative term reacts to the change rate in the process variable: if it changes 
considerably, the derivative control reacts robustly. This term is given by the equation: 
dt
tdeKD d
)(
=
 
Equation 9: Derivative term from the PID controller, where D is the derivative term of output, Kd is the 
derivative coefficient and e(t) is the  control error.  
 
The derivative term controls the rate of change in the controller output, which is 
more obvious close to the setpoint. This term reduces the overshoot produced by the 
integral term and improves the system’s stability. However, the signal’s differentiation 
amplifies its noise, so this term amplifies the noise of the process variable and it 
becomes unstable if the noise/derivative gain is too large. So, as differentiation is 
always sensitive to the noise, it’s therefore necessary to apply a low-pass filter, which 
attenuates the high frequencies, that is, the measurement noise from the process 
variable. [49], [51] 
 
3.10.4. Tuning 
The PID control success’s depends on the right choice of the control constants, 
which is also one of the most difficult steps in its implementation. There are several 
methods for the parameter’s calculation, which are often called tuning methods, such 
as the manual tuning, the Ziegler-Nichols and the Cohen-Coon methods.  
The Ziegler-Nichols methods are very well-known. They are based on the 
characterization of the process dynamics using a few and simple parameters and 
equations; they offer good tuning and are simple to apply. The step response method 
by Ziegler and Nichols is based on the process information, which has the form of an 
open-loop step response; that response is obtained as in the bump test. [50] The 
system lag and a general slope illustrated are used to set the PID gains. The generic 
system open loop step response of a first order system is shown next, as well as the 
curve parameters [52]:    
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Figure 26: Open loop step response of a first order system. [52] 
 
Based on the open loop response, the PID analogical gains are calculated 
using the follow equations, where L is the dead time and R is the slope of the curve 
[52]: 
LRK P **2.1=   L
KK PI 2
=   PD KLK **5.0=  
Equation 10: Ziegler-Nichols step response method to obtain the PID analogical gains. [53] 
 
After that, Takahaski suggested the following method to the tuning of a digital 
PID. The sampling time, Ts, and the controller gains are calculated with the follow 
equations [53]: 
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Equation 11: PID digital gains. [53] 
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3.11. Microcontrollers  
A microcontroller consists on a single integrated circuit with a central processing 
unit (CPU) combined with several support functions such as a crystal oscillator, timers, 
input/output ports, watchdog, and others. Microcontrollers are designed to work alone; 
they don’t need external components, since the peripherals are already built into them, 
which save time and space. [54] 
 
3.11.1. Memory 
The memory’s function is to store data and it contains all the memory locations. 
The input data has a certain address of memory location; so, when this address is 
selected it accesses the content in that location. Accessing contents in memory also 
takes a certain time to locate it. Besides reading from a memory location, memory also 
provide for writing onto it, through an additional line called the control line (R/W 
(read/write)). This line is used in the following way: if R/W=1, reading is done, and if 
R/W=0, writing is done on the memory location. [54] 
 
 
Figure 27: Memory unit, for a specific input there is a correspondent output, the control line R/W 
determines if we’re reading or writing to the memory. [54]  
 
3.11.2. Central Processing Unit 
The CPU is constituted by memory locations, called registers, which allow the 
microcontroller to implement various types of mathematical operations, as multiplying, 
dividing, adding and subtracting, and other types of operations with stored data from 
the memory unit. [54] 
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Figure 28: CPU with three registers. [54] 
 
3.11.3. Bus 
The bus is a line throughout data goes from one block to another. 
Consequently, connecting the memory and the CPU using busses gives the 
microcontroller functionally. The bus is constituted by a group of 8, 16, or more wires. 
Microcontrollers have two types of buses: address and data. The address bus is 
composed by as many lines as the amount of memory that is addressed and it’s used 
to transmit addresses from the CPU to the memory unit. The data bus is as wide as 
data or the connection line and it’s used to connect the blocks inside the 
microcontroller. [54] 
 
Figure 29: Address and Data Bus, connecting the memory unit and the CPU. [54] 
 
3.11.4. Input/Output Unit 
Input/Output unit is used to communicate with the outside devices and also to 
gate information. This block is constituted by memory locations where one end is 
connected to the data bus, and the other is connected to the output lines, which are the 
pins of the microcontroller. These locations are called ports, which can be input, output 
or even bidirectional ports. Through the ports, it can be read and be written information. 
[54] 
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Figure 30: Input/Output Unit. [54] 
 
3.11.5. Serial Communication 
Serial communication is a process of communication where data is send as one 
bit at one time sequentially over a communication channel. It is sent a start signal prior 
to each byte and a stop signal after it. The start signal is used to prepare the 
information’s reception, while the stop signal brings the receiving to rest in preparation 
for the next byte’s reception. Serial communication differs from parallel communication 
where several bits are sent together through several parallel channels. [55] 
The serial communication block enables the full-duplex communication, where 
there are separated lines to receive and send information, which can occur at the same 
time. After receiving the information, it is read from the receiving location and stored in 
the memory. To send information, data goes from the memory through the bus to the 
sending location and then to the receiving unit.  
The communication obeys to a communication protocol, which is a group of 
rules for exchanging data.  [54] 
 
Figure 31: Serial communication block. [54] 
 
3.11.6. Timer Unit 
The timer unit gives helpful information about time and duration. It’s composed 
by a free-run counter, which is a register. Therefore, the register value is periodically 
incremented by one in constant intervals. [54]  
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Figure 32: Timer Unit. [54] 
 
3.11.7. Watchdog 
The watchdog block is a free-run counter where the program writes “0” every 
time it executes correctly. If occurs any problem in the program execution, the 
watchdog won’t write “0” and the counter will reset the microcontroller when it gets to 
its maximum value. Then, the program is executed again and correctly. [54] 
 
 
Figure 33: Watchdog. [54] 
 
3.11.8. Analogue to Digital Converter 
 
The outside signals are usually different from the ones in microcontrollers; they 
often are analogue, and the microcontroller can only recognize digital signals, which 
are either “0” or “1”. So, external signals must be converted from their analogue value 
to a digital number that can be processed by the CPU. This task is executed by the 
analogue to digital converter block. [54] 
 
 
Figure 34: Analogue to Digital Converter. [54] 
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3.12. Microcontroller PIC24HJ128GP306 
 
The microcontroller used in the system is the 16-bit microcontroller 
PIC24HJ128GP306 from Microchip®. In this area, the student focused the Theoretical 
background in the specific modules involved in the valve’s integration and actuation. 
 
 
 
 
 
Figure 35: PIC24HJ128GP306, from Microchip®. [56] 
 
3.12.1. Timers 
The PIC24 has nine 16-bits timer modules (Timer1 to Timer9), which have the 
same functional circuitry but they also have some differences, so they’re classified in 
three types: Type A (Timer1), Type B (Timer2, Timer4, Timer6, Timer8) and Type C 
(Timer3, Timer5, Timer7, Timer9). Type B and Time C timers can be concatenated to 
compose 32-bit timers. The Timer module supports different modes of operation, which 
are the timer mode, the gated timer mode, the synchronous counter mode and 
asynchronous counter mode, which is only available in Type A timer. In timer and 
gated timer modes, the input clock is used the internal instruction cycle clock, while in 
synchronous and asynchronous counter modes, the input clock is derived from the 
external clock input at the TxCK pin. [57] 
 
3.12.2. UART 
The PIC24 also contains two Universal Asynchronous Receiver Transmitter 
(UART) modules, UART1 and UART2. UART is a module of serial input/ output that 
enables serial communication with peripheral devices, such as personal computers, 
and uses communication protocols like RS-232 and RS-485. This module is full-duplex, 
with 8 or 9 bit data communication, receiving and transmitting data through UxRx and 
UxTx pins of the PIC, correspondingly. The UART uses the Non-return-to-zero protocol 
to communicate, which is 1 start bit, 8 or 9 data bits and 1or 2 stop bits. The UART1 
uses RS-485 as input/output, while UART2 uses RS-232. [57] 
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3.12.3. Pulse Width Modulation 
 Pulse Width Modulation (PWM) of a signal or a power source is a technique for 
controlling analogue circuits with a processor’s digital output and it’s used in a large 
variety of applications, such as communications, conversion and power control due to 
its low power, noise-free and low cost. [58], [59] 
The PWM’s control uses a square wave whose duty cycle is modulated. The 
duty cycle is the amount of time in the period that the pulse is high and usually is 
specified as a percentage of the pulse period, as indicated in equation 2. 
 
Figure 36: A square wave with 50% of duty cycle. [59] 
 
100×=
− periodclk
pulse
T
T
CycleDuty     Equation 12: Wave’s duty cycle. 
 
CCVCycleDutyVoltageAverage ×=    Equation 13: Wave’s average voltage. 
 
By varying the square wave’s duty cycle its width is modulated resulting in the 
variation of the average value of the waveform and generating a variable output 
voltage, by means of a repeating series of on and off pulses. [59], [60]  
In the next figure, there are represented three different PWM signals. The first 
wave has a PWM output at a 20% duty cycle, so the signal is on for 20% of the period 
and off the other 80% of the time. The second and third waves have PWM outputs at 
50% and 90% duty cycles, correspondingly.  
  
 
 
 
 
 
 
 
 
 
Figure 37: PWM signals with different duty cycles, the signal is in high level for 20%, 50% and 90% of 
the period respectively. [61] 
20% Duty Cycle 
50% Duty Cycle 
90% Duty Cycle 
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The PWM signal is digital because, at a certain instant of time, the signal is 
either completely on or completely off. [58], [59] 
 Microcontrollers have PWM outputs using a counter, the timers, which is 
periodically incremented by a clock signal internal or external to the digital circuit. 
When the counter period is equal to the reference value, the PWM output changes 
state; the counter reset when it gets to the PWM’s period. The duty cycle is therefore 
varied in discrete steps and it’s a function of the timer resolution, which is the highest 
number of pulses that can be packed in the PWM period. [60] 
 
3.12.4. Output Compare 
The Output Compare module has several associated operational modes. 
Generally, this module compares the value of the timer with the value of one or two 
compare registers depending on the operating mode selected. Then, the state of the 
output pin changes when the timer value matches the compare register value. The 
output compare module generates either a single output pulse or a sequence of output 
pulses, by changing the state of the output pin on the compare match events. 
To control the voltage applied in the valve’s solenoid it was used the PWM 
mode without fault protection of this module. This mode is similar to PWM mode with 
fault protection, but this one can be activated externally. This module uses a timer 
which has to be Timer2 or Timer3; this resource is selected by configuring the Output 
Compare Timer Select (OCTSEL) bit in the Output Compare Control register.  
The PWM mode is used to generate variable duty cycle output. The selected 
timer starts counting from zero and increments on every clock until it reaches the value 
in the Period Register (PRy). The Compare Register (OCxR) value is continuously 
compared with the timer value and when the match occurs, the OCx pin is driven low. 
When the period value is reached, the timer resets to zero and starts incrementing 
once again. The timer can be clocked using an internal clock source (FOSC/2) or a 
synchronized external clock source applied at the TxCK pin. The PWM duty cycle is 
specified through Secondary Output Compare (OCxRS) register, and the Output 
Compare (OCxR) register is a read-only compare register. [57] 
   
( ) ( )ValueescaleTMRyTCyPRyPeriodPWM Pr1 ××+=  
Equation 14: PWM period calculation. 
2
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4. State of the Art 
There isn’t available in the market any device that controls in real time and 
automatically the oxygen flow to the patient, based on his real needs and that can 
prevent waste of oxygen. The equipments available only enable the manual control. 
Nevertheless, there is under development a system to achieve that goal, which is near 
to the one we proposed to build up in many points. There are also studies which 
confirm the efficiency of the saturation driven oxygen therapy, where the patient’s SaO2 
is used to control the oxygen’s delivery, establishing a dynamic therapy. There are also 
some studies to implement a PID controller in mechanical ventilators and also in neo-
natal units to maintain the patient’s oxygen saturation as close as possible from a pre-
defined value defined by the clinicians and more accurately control its variation. Those 
studies are mentioned later in chapter 6. 
 
4.1. Saturation Driven Oxygen Therapy 
The Department of Bioengineering, South Kensington Campus of London has 
simulated a method to automatically regulate the oxygen flow rate in response to the 
measured oxygen demand by pulse oximetry, which is called the Saturation Driven 
Oxygen Therapy (SDOT). This type of treatment uses the oximetry measurements to 
accurately control the flow as a feedback system, on that way, the therapy matches the 
patient needs to oxygen supply more exactly than in the conventional fixed flow 
therapy. The system simulated consisted in a controller that receives the pulse 
oximeter measurements of oxygen saturation and computes the error (E(t)) between 
the target setpoint and the oximetry value measured. Then, the controller determines 
the optimum oxygen flow rate and outputs a signal to a flow regulator, managing the 
delivery of oxygen to the patient. The feedback from the pulse oximeter enables the 
controller to handle the oxygen flow, since there is feedback of SpO2 to the closed-loop 
controller to safer control the output. Furthermore, the microcontroller is programmed 
with the PID algorithm to compute the correct dose of oxygen. [2] 
 
 
Figure 38: Block diagram of the system tested. [2] 
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To the patient safety, the oxygen flow had limits, a maximum (5 lpm) and a 
minimum (0 lpm), which were provided by a non-linear saturation regulator. The group 
had also developed a mathematical model to modulate the patient blood oxygen 
saturation response due to the flow’s variations, through the study of the PaO2 
variations. Accordingly, the PaO2 is modelled by the follow equation: 
)()()()( 02 mmHgtPtPPtPaO fd ++=  
Equation 17: Patient arterial oxygen concentration model. [2] 
 
The equation has three terms; Po, a baseline level, Pd, an arbitrary disturbance 
and Pf, the flow rate dependence. Where Po≈60 mmHg in the absence of disturbances 
or any oxygen flow and the arbitrary disturbance is given by: 
)**2cos(33)( tftPd pi+−=  
Equation 18: Arbitrary disturbances introduced by the variable conditions possible in COPD patients 
during sleep and exercise. The frequencies used in the simulation varied between 10-3 and 10-1 Hz. [2] 
 
The patient’s oxygen flow dependence, Pf is described by a second order linear 
differential equation that relates the oxygen flow rate (U) to the arterial oxygen 
concentration: 
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Equation 19: Patient’s oxygen flow dependence. [2] 
 
 α is a sensitivity factor that is for each additional lpm of flow provided, the FiO2 
increases 3% and it was assumed that also the PaO2 increases 3% with each 
additional l/min of oxygen. 
The pulse oximeter measures the arterial oxygen concentration as a percent of 
saturation. So, to obtain the arterial oxygen concentration in mmHg it’s used the 
oxyhaemoglobin dissociation curve which equation is given next: 
( )[ ]
046.0
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2
SpOPaO −−=  
Equation 20: Oxyhaemoglobin dissociation curve. [2] 
 
 
The system has been simulated on Simulink™ (Matworks, Inc, Massachusetts 
USA) and the results were compared against a simulation of untreated and continuous 
LTOT patients. The “No Oxygen Therapy” group was composed by three COPD 
patients where was collected saturation data in the sleeping period using an oximeter 
during 8 h. Then, this information was incorporated in the simulation, with the previous 
conversion of the SpO2 readings to PaO2 values (using the oxyhaemoglobin 
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dissociation curve). The SDOT group represents the results of the automatic control of 
the flow with the controller and the continuous LTOT was also simulated. The results 
obtained and the comparison of the therapies are summarized in the next table:  
 
Table 5: Comparison of the therapies. 
 
 The values of SpO2 obtained were compared with the values from the patients 
without supplemental oxygen and the SDOT demonstrated that it attenuated the 
fluctuations, by varying adequately the flow rate. As can be seen in the table above, the 
SDOT maintained the SpO2 above the threshold, improving the efficacy of the 
treatment, when compared to standard LTOT. This simulation demonstrated the 
potential efficiency of the closed-loop flow control, with an improvement in the oxygen 
saturation. [2] 
 
4.2. SmartBlenderTM, Columbia Life Systems 
 
Columbia Life Systems provides devices to the adaptive adjustment of the 
oxygen delivery to people recovering from respiratory distress. Their device, 
SmartBlenderTM, was developed with the contribution of neonatologists and respiratory 
therapists to modernize the current standard of care worldwide. This device is an 
oxygen blender, which mixes oxygen with air, controlling the oxygen flow rate and 
concentration and it automatically controls the amount of oxygen delivered to patients. 
The SmartBlender™ is composed by a pulse oximeter connected to a minicomputer 
that is programmed to adaptively adjust the oxygen blender that supplies the oxygen 
mixture to the face mask or nasal cannula. Consequently, it will adjust more accurately 
and timely the supplemental oxygen to the patients. The computer also includes an 
extensive variety of safety features to ensure patient safety. [62] 
Group Variables Patient 1 Patient 2 Patient 3 
Mean overnight SaO2 (%) 88.8 91.8 95.1 
Standard deviation SaO2 (%) 4.6 2.3 3.3 
Percent Time vw’ SaO2<90 (%) 55.1 27.3 12.1 
 
No Oxygen 
Therapy 
Recording Duration (min) 483 483 483 
Mean overnight SaO2 (%) 91 92.5 95.4 
Standard deviation SaO2 (%) 2.6 1.6 2.7 
Percent Time vw’ SaO2<90 (%) 22.9 4.3 1.8 
 
 
SDOT 
Mean flow-rate (L/min) 2.3 0.9 0.4 
Mean overnight SaO2 (%) 90.7 92.3 95.3 
Standard deviation SaO2 (%) 3.7 2.1 3.2 
O2 equivalent 
constant flow 
LTOT Percent Time vw’ SaO2<90 (%) 36 15.9 8.5 
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Figure 39: SmartBlenderTM and its setup panel. [62] 
 
4.3. Self-Regulating Oxygen Delivery System 
 
 The Biomedical Engineering Department from the University of Michigan, 
U.S.A., in cooperation with the Department of Computer Science from Purdue 
University, U.S.A., has been working in a project of a Self-Regulating Oxygen Delivery 
System. The goal of this project was to design a self-regulating device to control the 
oxygen flow to the patient based on SpO2 readings and automatically adjust the valve 
opening based using the pulse oximeter signals. The device also has some features 
like portability, safety, user-friendly and cost-effectively, thus it could be used either at 
the hospital or at home. [63] 
 The system consists in a Freescale HCS12 Microcontroller, an Electronic 
Proportional Valve (Parker HF Pro Valve), a BCI Pulse Oximeter Sensor and Board, 
connected in the way represented in the next figure: 
 
 
Figure 40: Project Design, representing the connections between the HCS12 Microcontroller, the 
Electronic Proportional Valve (Parker HF Pro), the BCI Pulse Oximeter Sensor and Board with the patient 
and the oxygen source. [63] 
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The BCI pulse oximeter sensor collects and sends data to BCI oximeter board. 
Then, the BCI oximeter board calculates the SpO2 and sends a signal to the 
microcontroller via serial communication interface. The SCI uses an EIA-232 
transceiver to enable the communication between the oximeter board and the 
microcontroller. HCS12 determines whether the valve opening needs to be adjusted if 
oxygen saturation is outside of the desired range. Then, it sends a voltage to the 
proportional valve using PWM’s signal to adjust the valve’s opening. Parker HF Pro 
valve controls the flow of gas proportional to input variable voltage and provides 
oxygen safe. When there’s no input voltage the valve is closed and opens completely 
when the maximum voltage value is supplied. [63] 
 
Figure 41: Prototype of the device, showing the Microcontroller HCS12, the proportional valve and also 
the connections to the oximeter, the oxygen source and the patient. [64]   
 
 This is a very recent project from 2008, so the prototype of the device was in 
implementation at the time of the article’s writing. Based on the research made by their 
developers, the automatic oxygen delivery system showed to be more efficiently than 
manual delivery systems; the patients did spend effectively more time with optimal 
oxygen saturation which will effectively decrease the workload of the caregivers with 
each patient. Furthermore, it is more cost-effective and portable than other devices 
studied. [63] 
 
 
 
 
 
 
Oxygen Source 
To patient 
Valve 
HCS12 
Signal from  
oximeter board  
and sensor 
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4.4. Advantages of the proposed solution 
The projected solution is close to the project presented by the Biomedical 
Engineering Department from the University of Michigan. They have in common some 
characteristics and goals, as to be safe, efficient and a user-friendly device. However, 
the system planned has some features that will certainly improve its performance and 
effectiveness. So, the accelerometer will introduce dynamic parameters in the flow 
control, making the therapy customized according to each patient’s need and degree of 
motion. The system’s optimization is going to pass certainly to the implementation of an 
oxygen conserving technique, thus allowing the oxygen saving and extending the 
reservoir duration, improving the patient mobility and reducing the therapy costs. The 
actuation of the valve using the hardware developed by its manufactures is also an 
advantage, since it compensates the deviations that occur with temperature rising, thus 
providing more precise control during its utilization. In addition, the control of the valve 
is done in current, which is more accurate than in voltage. Furthermore, the proposed 
device uses a customized valve, according not only with the required flow, but also with 
the voltage provided by the microcontroller. 
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5. System Development 
5.1. System’s Goals 
The proposed system intends to adjust the oxygen flow automatically and 
precisely to a respiratory failure patient based on the SpO2 readings, measured by 
pulse oximetry, and movement, measured by accelerometry. The automatic control of 
the oxygen deliver has two elementary goals: it intends to assure that the patient 
spends more time with optimal oxygen saturation and realizes the full potential benefits 
of the therapy and also to prevent the waste of oxygen, thus reducing the total costs of 
the therapy. As a medical device, it has some other goals as to be safe, rapid to act in 
response to blood oxygen desaturations and furthermore, it must be easy to use, since 
it’s a device to apply in home oxygen therapy. In addition, it must be lightweight and 
have small dimensions. 
 
5.2. System Architecture 
The system has the architecture shown in the next scheme: 
 
Figure 42: System Architecture, representing the connections between the Leonardo Platform, which 
contains the Microcontroller, the Electronic Proportional Valve, the Driver Board, the OxiLinkTM Pulse 
Oximeter, the iDemo board and the XYZ Plux Accelerometer with the patient and the oxygen source. The 
dotted line corresponds to the part of the prototype not implemented yet. 
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As represented in the system architecture above, the Leonardo Platform, which 
has integrated the microcontroller PIC24HJ128GP306, controls the all system: it 
receives through three analogue entries (one for each axis) the data from the 
accelerometer (XYZ Plux Accelerometer), which gives the information about the patient 
movements. It also receives the information about the patient’s blood oxygen saturation 
from the pulse oximeter (OxiLinkTM Pulse Oximeter), using a finger sensor. The 
oximeter sends data to the iDemo board through RS-232 and it has a transceiver that 
converts the input signal to TTL and then sends it to the microcontroller, directly to the 
U1Rx port (receiving port) of the UART1 module from the microcontroller. Then, the 
PIC sends a PWM signal to the driver board, using its Output Compare Module in 
PWM mode, based on a controlling algorithm. The driver board, which is the valve’s 
hardware of actuation, converts the input voltage in a proportional and amplified 
electrical current to be applied in the electronic proportional valve’s solenoid. According 
to the amount of current, the valve’s opening varies, controlling consequently the 
oxygen delivered from the oxygen source to the patient. Also, some customized 
adapters are used to safety connect the valve’s ports and the oxygen lines. 
 
Figure 43: Prototype of the system and its associated components. 
 
The accelerometer isn’t included in the prototype implemented for now, 
although it was planned and studied its incorporation, this will be a future development 
of the system. 
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It’s therefore a closed-loop system inherently characterized by a close 
cooperation of different devices: sensors to measure the patient’s diagnostic 
parameters, a controlling algorithm and a therapeutic device that actuates in the 
oxygen source. As a clinical device, it has to deal with very complex physiological 
processes and must react promptly and properly on a diversity of physiological 
conditions and events.  
 
 
 
 
 
5.3. System Apparatus   
 
 During the first stage of the project, the student was focused in the research for 
devices to apply in the system, specially the pulse oximeter and the medical oxygen 
valve. Afterward, with the course of the project, it was also needed to purchase other 
equipments to optimize the system and face the problems that toke place. As result, 
there were analyzed numerous equipments from several companies and there were 
made some contacts with their sales managers, in order to assure that the devices’ 
features were according to the system’s goals.  
As represented in the system architecture, the apparatus is composed by the 
Leonardo Platform, the Kelly Pneumatics electronic proportional valve and its hardware 
of actuation, the driver board, the adapters, the OxiLinkTM pulse oximeter and finger 
sensor and the XYZ Plux accelerometer. Each of the system’s components and their 
technical features are discussed in detail bellow, including the accelerometer although 
it wasn’t included. 
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5.3.1. The Leonardo Platform 
The Leonardo Platform is a board developed by ISA to remote vital signs 
monitoring and telemetry applications.  
The Platform has many potentialities and includes several components, as a 
microcontroller, the PIC24HJ128GP306, which is the most important device from the 
board in the current system. The PIC receives data from the patient that is being 
monitored; through the pulse oximeter it receives the oxygen saturation readings and 
through the accelerometer it receives the information about the movement, shock or 
vibration. The reception of data takes place using wire connections; the oximeter sends 
data to the iDemo board through RS-232 connection, which communicates with the 
Platform, directly into the PIC, in its UART module. The accelerometer communicates 
with the PIC through three analogue entries. With these data, the PIC microcontroller 
determines whether the valve’s opening needs to be adjusted, based on the controlling 
algorithm. That is, the PIC processes the oxygen saturation value and determines the 
adequate output flow, supported by an algorithm founded in clinical conditions. To vary 
the valve’s opening, the PIC uses its PWM mode and varies the output compare 
register, thus changing the output voltage in the output compare pin, to the driver 
board. As result, the PIC is responsible for the therapeutic device control. The Platform 
is supplied with 12 VDC, which also supplies the driver board.  
 
Figure 44: Leonardo Platform, showing the microcontroller, the LED’s, the reset button and the pin of the 
output compare module. 
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The board has a reset button that was used to implement a panic button. If the 
patient, for any reason, fells that isn’t receiving enough oxygen or if happens any 
problem with the valve’s opening, the button is pressed and the valve is opened at its 
maximum diameter, delivering the maximum output flow, which is 7 lpm. When 
pressed, the button modifies the state of the PIC’s pin (from 0 to 3.3V), which is 
detected by the algorithm and then actuates on the valve opening at its maximum 
diameter.  
The Platform has three LED’s, two red LED’s and one green LED. The green 
LED is light when the Platform is being supplied. The red LED’s were used to do, not 
only tests in the system, but also to confirm that the oximeter’s data was correctly 
received, since when the oximeter sensor detects the absence of the finger, the red 
LED lights.  
 
 
5.3.2. The Electronic Proportional Valve and the Driver Board 
As mentioned before, in the first phase of the project, it was made a research 
on medical oxygen valves. Those ones were only mechanically and they didn’t allow a 
wide variety of output diameters, additionally, the flow provided was only regulated 
manually. However, electronic proportional valves, which are used throughout the 
industry in many flow and pressure control applications, were studied and considered 
the best option to apply in a device like this. They are small, low powered and can be 
controlled by voltage/current in a wide variety of output diameters thus allowing a 
dynamic control of the output flow. Consequently, after some researches, there were 
selected a few companies that have on the market this kind of equipments. After 
analysing several possibilities, the valve selected to this project was the miniature 
proportional valve from Kelly Pneumatics. This valve satisfies the project’s 
requirements, since it is low power with small dimensions and has already been used 
in medical oxygen applications, although not in home care therapy. The valve is 
normally-closed type with two ports, one inlet and one outlet port. It has a frictionless 
performance and longevity, tested over 100 million cycles. It was also customized by 
the manufacturer according to the project’s requirements (output flow varying from 0 to 
7 lpm). With the proportional valve it was also purchased its actuation hardware, the 
driver board, also from Kelly Pneumatics. It is developed according to the valve’s 
features and it’s the ideal solution to operate it. The driver board can be controlled by 
PWM’s output voltage from the microcontroller, which varies from 0 to 3.3V. 
Accordingly, the voltage sent by the PWM’s signal is proportionally converted and 
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amplified to electrical current by the driver board and then is applied in the electronic 
proportional valve’s solenoid. 
 
 
Figure 45: The Miniature Proportional Valve and the Driver Board, from Kelly Pneumatics. 
 
Some of the valve and drive board’s features are shown in the next table: 
 
Table 6: Technical specifications of the electronic proportional valve and driver board, from Kelly 
Pneumatics. 
 
The working pressure of the valve is according with the source’s pressures, 
since the hospital’s sources have 1.5-2 bar (21.75-29 psi) of output pressures. 
The flow range of biological significance was considered 0 to7 lpm according to 
Doctor Moita’s guidance, once there aren’t available devices with higher flow rates than 
5 lpm and it isn’t regular practice to deliver more than 5 lpm. So, in preventing unusual 
cases, the system can provide till 7 lpm.  
 
Electronic Proportional Valve Driver Board 
Electrical Connection Wire leads Voltage Required 12 VDC 
Port type #10-32 Inline Operating Temperature 0-65ºC 
Orifice Size 0.010  inch Input Signal 0-3.3 VDC 
Maximum Pressure 25 psig Power Supply <3 W 
Voltage Supply 0 to 5 VDC 
 
Valve Type 2- way 
Operating Temperature 0-50ºC 
Response Time 3 to 5 ms 
Seal Material Buna-N 
Weight 0.125 lbs 
Output Flow 0 to7 lpm 
Input Signal 
Ground 
Power Supply 
Driver Board 
Miniature Proportional Valve 
 Valve’s port 
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5.3.3. Valve Adapters 
To strongly connect the valve and the oxygen lines adapters are used. They fit 
in the valve inlet and outlet ports and also in the oxygen tubes. The adapters were 
provided by Kent Company, who usually provides these equipments to the Kelly’s 
valves. In fact, this company was directly recommended by Kelly Pneumatics. 
The adapters are straight connectors, threads to flexible tubing and are made of 
Kynar (PVDC-polyvinylidene fluoride), besides they’re very cost effective. They are 
according to the valve’s ports dimensions (#10-32 tapered valves) and also with the 
oxygen cannula inlet dimensions (4 mm) and material (soft materials, as silicone, latex 
and polyethylene). The coupling enables the safe and easy connection and 
disconnection of the tubes and fits in the valve’s inlet and outlet ports to ensure the 
correct insulation when oxygen is passing through the lines. 
 
 
 
Figure 46: Valve Adapter from Kent, scheme and photo, straight connector thread to 4 mm of inside 
diameter to #10-32 tapered valves. 
 
 
Figure 47: Electronic Proportional Valve with the Valve Adapters, from Kent, in the inlet and outlet ports. 
 
 
 
 
 
 
 
 
 
 
 
 
 Valve Adapter 
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5.3.4. The Pulse Oximeter 
 Arterial blood gases must be repeatedly monitored in a non-invasive way, so 
the integration of a pulse oximeter is very helpful. Its data allows a fast and easy way to 
access the efficiency of the treatment, because SpO2<90% are undesirable and 
negative to the patient’s health. The data obtained with the pulse oximeter is used as a 
feedback signal to maintain the patient SpO2 within the ideal range, pre-defined by the 
clinicians. So, the oxygen delivery is increased or decreased based on the data 
acquired on the patient in the real time monitoring. 
 After taking into consideration several devices, the OEM pulse oximeter chose 
to be applied in the system is the OxiLinkTM OEM Pulse Oximeter from Smiths Medical. 
It was taking in consideration many aspects, such as it connector option that should be 
RS-232, as well as the ability of linking different types of sensors (finger, ear) and also 
the providence of the communication protocol, which enables the use of the oximeter in 
integrated solutions.     
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48: OxiLinkTM Oximeter, from Smiths Medical, showing the finger sensor and the RS-232 
connector. The oximeter is contained in the cable. 
 
The OxiLinkTM OEM Pulse Oximeter has great flexibility, since it allows the 
choice of the sensor (finger, ear) and also the connection option, as it has two 
connector options, RS-232 and USB. Furthermore, it’s low power (25 mW), which is 
important in the system’s autonomy and portability.  
Since there were some problems with the communication between the oximeter 
and the Leonardo Platform, there was used an iDemo board to establish the 
communication between both of the equipments. The iDemo board has a transceiver 
that converts the input signal in RS-232 form to TTL form, which is then received by the 
PIC’s UART module, via UART1 Rx port. Therefore, the OxiLinkTM measures the SpO2 
Oximeter 
Finger Sensor 
RS-232 connector 
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and it’s connected to an iDemo board through RS-232 and the iDemo board 
communicates with the Leonardo Platform directly in the UART receiving port.  
 
Figure 49: The iDemo board. 
 
 
5.3.5. Accelerometer 
 The accelerometer chose to be applied in the system was the XYZ Plux 
accelerometer, from Plux Company. This device is wire connected to the Platform 
through three analogue entries and incorporates the ADXL330 accelerometer from 
Analogue Devices. It’s a three measurement axis accelerometer, with small dimensions 
(4mm x 4mm x 1.45 mm) and low power (usually 200µA), which measures the static 
acceleration of gravity, as well as the dynamic acceleration (motion, shock and 
vibration). 
 
Figure 50: XYZ triaxial Plux accelerometer, from Plux. 
 
  By applying an accelerometer in the system, it’s expected to be possible the 
control of the oxygen flow according to the patient movements, establishing a dynamic 
therapy, based on his real and own needs. As well, because each patient is unique, the 
data obtained with the accelerometer must be considered individually in cooperation 
and with the support of the clinicians. So, in the first stage, the accelerometer will only 
be used to acquire data, while the flow rate is controlled only through the oximeter 
readings. The information collected will be therefore, not only the patient’s movements, 
but also the desaturations that occur due to the daily physical activities. Following, in 
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cooperation of the clinicians, the data collected during several periods of time will be 
analysed to establish the pattern to each case.  
The final goal is to relate the degree of movement with the saturations/ 
desaturations to a well known flow, and predict the quantity of oxygen that the patient 
will need with that degree of motion, avoiding desaturation periods and their negative 
consequences, especially to the lungs. Like this, the therapy will match more efficiently 
each patient requirements and it will be according to the mobility of the patient. In fact, 
with the application of the accelerometer it’s expected to increase the patients’ mobility 
and the level of activity, which is highly recommended in pulmonary diseases to slow 
the illness’s progression. 
As mentioned before, the accelerometer’s integration was studied, but it wasn’t 
performed yet. 
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5.4. System Features  
 
As it intends to be a safe and user friendly device, the system has to have some 
features that must be assured. As it must be safe, it has implemented the panic button, 
to assure the continuous flow if some problem happens. In the absence of the finger 
the system provides a continuous flow of oxygen (2 lpm) and that also increases the 
device’s safety. In addition, the use of the adapters also contributes to the system’s 
security, as they enable the correct connection of the oxygen lines and assure the 
appropriate insulation.  
The device also has to be easy to use; the patient should just put the oximeter 
sensor in the finger and the oxygen cannula to receive the correct oxygen dose during 
the daily activities and also the sleeping hours. The usability of the device is therefore 
assured, since the system is easy to use at home by the patient. Since it is a system to 
attach in an oxygen source, it should be robust and have small dimensions.  
The system must be reliable to promptly react to the desaturations increasing 
the flow, but also decreasing it when the patient is stabilized, to safe oxygen, extending 
the container’s duration and thus reducing the therapy’s costs. As well, the system’s 
response time must be as low as possible, specially to prevent desaturations during 
higher levels of motion, where the blood oxygen saturation falls rapidly. The reliability 
of the system depends on the correct communication between the sensors, the 
Leonardo Platform and the proportional valve. Furthermore, the system’s performance 
depends on the correct data acquisition by the sensors and its processing; after that, 
the system should respond in accordance with the data pre-defined parameters and, as 
well, it should be able to act effectively on the valve so that the flow of oxygen would be 
carried out correctly. 
It is a customized system, since the valve’s actuation is only based in the 
patient’s oxygen saturation monitoring and later in his movement, through a 
personalized therapy “designed” by the clinicians.  
Since the system has small dimensions and is also lightweight, it can be 
converted in a portable device in the future, once the Leonardo Platform has the ability 
to be supplied with batteries. As mentioned before, there are available three oxygen 
sources. This system was designed to be applied in a general oxygen source, but the 
ideal solution would be a portable one, like the LOX portable container’s bag, to extend 
its durability and also to react to the dynamic requests of the patients during their daily 
activities outside home.  
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5.5. Other System’s Apparatus 
 
Other components, besides those one shown in the logic architecture, were 
studied to be included in the present device to add functionalities to it. Besides the 
control of the output flow using the saturation measurements to vary the valve’s port 
diameter, the system also has to have some other apparatus to improve its 
performance.  
The device must allow the oxygen’s saving, with the aim of increasing the 
durability of the source. The implementation of a conservation technique was studied, 
since it would not only increase largely the source’s durability but also contribute to the 
system’s optimization. Currently, there is available a large number of oxygen’s 
conserving valves, which only deliver oxygen during the inhalation. The first approach 
was to connect the two valves, the oxygen conserver valve and the electronic 
proportional valve, in series. But, since each one has its associated electronics, both of 
them could come into conflict and their actuation could be compromised, which would 
by risky to the patient. So, this approach was putt aside. A second approach studied, 
but also not implemented, was the modulation of the respiratory cycle using a 
respiratory effort band. Those bands have piezoelectric sensors that convert kinetic 
energy into electrical current, enabling the register of the changes in thoracic and 
abdominal volume due to the expansion of chest and abdomen in the respiratory cycle. 
The band would therefore detect the inhalation/exhalation and that would enable the 
modulation of respiratory cycle. If the system could detect the respiratory cycle phase, 
it would be able to delivery oxygen only in the inhalation. Nevertheless, these 
hypothesis were only studied and not implemented in practice, so the system hasn’t 
implemented none oxygen’s conserving device.   
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5.6. Valve’s Integration and Actuation 
The electronic proportional valve is controlled through the electrical current that 
passes in the valve’s solenoid. As it varies, the outlet diameter varies, due to the 
magnetic field changes, varying the output flow, as well. However, the valve has two 
typical behaviour curves of electrical current versus flow rate for each working 
pressure. There are two curves because of the equipment’s hysteresis; one for the 
increasing and another one for the decreasing of the current. This happens because 
the valve has different behaviours when the electrical current is increased and 
decreased. This means that it is necessary to know the path that the input followed 
before it reached its current value when the valve is being actuated. The curves for a 
standard miniature proportional valve from Kelly Pneumatics are presented next:  
 
 
Graphic 1: Valve's curves of electrical current versus flow rate to an inlet pressure of 20 psig.  
 
The valve can be operated either in electrical current or in voltage. 
Nevertheless, the control of the valve in current is more effective, so, the driver board 
operates the valve applying it the desired current. The valve’s control in current is more 
accurate than in voltage, due to the Joule’s Effect. As the temperature increases, the 
coil resistance goes down and requires more voltage to maintain the same current. So, 
the driver board actuates to compensate this effect: it automatically compensates the 
temperature rising by controlling current to the coil. The flow is proportional to current; 
therefore, when temperature rises the driver board continues to deliver the same 
current to the coil thus maintaining the flow steady, regardless of whether the 
temperature is rising or dropping. Furthermore, the driver board not only compensates 
the deviations due to the temperature rising, but also the deviations caused by 
hysteresis, referred previously, which simplifies the valve’s control.    
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5.6.1. Electronic Proportional Valve Calibration Curve 
 
The PIC actuates the driver board through the PWM’s signal, which is a voltage 
signal. Then, the voltage applied in the driver board is proportional amplified and 
converted to an electrical current and it is applied in the valve. Therefore, the control of 
the valve by the driver board is more effective, since it is done in current, and also 
more precisely, since the driver board is designed to compensate the deviations 
caused by hysteresis and temperature rising. As mentioned before, the valve was 
calibrated according to the project features and the manufacturer provided three 
calibration points, which are indicated in the next table: 
 
Flow (lpm) Voltage (V) 
0 1 
7 3.3 
12.5 5 
Table 7: Valve's calibration points, provided by its manufacturer. 
 
Based on these points, it was obtained the curve that relates the flow with the 
applied voltage. It was only used two points ((0, 1) and (7, 3.3)), since the useful flow 
ranges from 0 to 7 lpm and the third point would cause deviations. The referred curve 
is presented next, as well as the linear fitting: 
Flow Vs. Voltage
V = 0,3286d + 1   (V)
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Graphic 2: Curve of flow rate vs. input voltage based on the flow calibration points. 
 
)(13286.0 VdV +×=  
Equation 21: Relation between the input voltage and the output flow of the miniature proportional valve. 
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With this linear fitting, it has been obtained a direct relation between the input 
voltage and the output flow that enables the development of an algorithm to control the 
valve using the microcontroller’s signals (PWM’s signal). 
 
5.6.2. Valve’s Control Process 
 
The valve’s control is operated through the variations in the applied voltage, 
which are responsible for the valve’s output diameter variations, thus leading to 
different flow rates. The algorithm receives the value of the oxygen flow rate needed by 
the patient, d(n), which is determined according to the SpO2 readings from the pulse 
oximeter. Using d(n), the algorithm calculates the corresponding voltage, based on the 
curves’ linear fitting obtained above. This voltage is used to determine the percentage 
of the wave’s duty cycle, related to the 3.3V of output voltage supplied by the PIC. It 
then calculates the secondary output compare register (OCxRS) of the PIC’s Output 
Compare module, which enables to obtain the output voltage required by the PWM 
mode. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51: Process’s flowchart: with the needed flow rate d(n) is calculated the voltage, using the valve’s 
linear fitting. Then, it’s calculated the wave’s duty cycle percentage and the PWM’s register, OCxRS, to 
obtain the required output voltage. 
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This control process is just a voltage control once the electrical current control is 
entirely made by the driver board based in the input voltage. 
The firmware to control and actuate the valve is therefore simple, since it is 
based in a linear fitting from the valve’s calibration points and the driver board prevents 
the common deviations. Without the driver board, the valve’s actuation would certainly 
be more difficult and it could be less effective and accurate.  
 
To design this control method and operate the valve correctly, the PWM module 
and the associated timer were previously configured.  
The output compare pin used was the OC5 pin from the PIC, which can be view 
in the Leonardo Platform image above. This pin was configured as an output port, 
through the data direction register (TRIS) of the I/O ports. The TRIS register control bit 
determines whether the pin is an input or an output; if the TRIS bit is a ‘1’, the pin is an 
input, while if the TRIS bit is a ‘0’, the pin is configured as an output. The driver board 
was connected to this pin to receive the input signal. 
The PWM module chose was the PWM mode without fault protection, which is 
used to generate variable duty cycle outputs. That mode was selected through the 
output compare mode select (OCM) bits in the output compare control register 
(OC5CON). This mode generates several output pulses due to the changes in the state 
of the output pin, which is either high or low. The PWM duty cycle is specified through 
secondary output compare (OC5RS) register, while the output compare (OC5R) 
register is a read-only compare register.  
The OC5RS is continuously compared with the timer value, so, this mode needs 
a timer to operate. The output compare module works either with the Timer2 or Timer3. 
The timer used was the Timer2, which was selected by configuring the output compare 
timer select (OCTSEL) bit in the output compare control register. The timer is clocked 
with the internal clock source (FOSC/2) that was selected through the timer clock source 
select (TCS) bit in the timer2 control register (T2CON). Furthermore, the prescale 
factor used was 1:1, which is, each machine cycle corresponds to an increase of timer. 
That prescale value was configured in the timer input clock prescale select (TCKPS) bit 
also in timer2 control register. The timer was operated in timer mode by configuring the 
timer gated time accumulation enable (TGATE) bit in timer2 control register.  
The timer2 period register (PR2) enables the selection of the period value of the 
associated timer. As the PWM frequency used was 3 kHz, the PWM period is 3.33x10-4 
s and the timer period is obtained using the follow equation: 
( ) ( )ValueescaleTMRyTCyPRyPeriodPWM Pr1 ××+=  
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 The prescale value is 1 and, as the device operating frequency (FCy) is 
39628800 Hz, the TCy value is 2.52x10-8 s. Using the equation above, the PR2 
obtained was approximately 13209.  
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6. PID Controller’s Implementation 
 
6.1. The PID Controller Functionality 
 
The developed algorithm regulates the oxygen flow rate base in an empiric 
method, constructed according to Doctor Moita’s guidance. It was delineated by the 
clinicians of CHC that, for each 2% of oxygen saturation decreasing, the flow should be 
increased by ½ lpm. After the stabilization of the blood oxygen saturation, the output 
flow would be then reduced slowly. Based in these statements, the entire algorithm 
was developed.  
Although, since the system is closed-loop with feedback control, the 
implementation of a PID controller would be the desirable option to accurately control 
the output. It would consequently improve the system’s performance in the 
maintenance of the arterial blood oxygen saturation in the ideal range. The PID 
controller would calculate the input error between the measured oxygen saturation and 
the setpoint, which should be 90-91% of oxygen saturation. Based on this error, it 
would calculate the correspondent flow, thus approaching and maintaining the SpO2 to 
the setpoint or to an ideal range pre-defined by the caregivers. Hence, the PID 
manipulates the output in the direction that should move the process toward the 
setpoint using the automatic mode. 
The PID controllers are used in a wide variety of applications, so its 
implementation involves the calculation of the Kp, Ki and Kd parameters, which must be 
according to the system that is being controlled. As well, the PID algorithm must be 
"tuned" for the particular process loop, which is based on the dynamics of the process 
response, because without such tuning, it will not be able to function correctly. 
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6.2. PID Computer Implementation 
 
The PID controller’s digital implementation in computer consists in the 
discretization of the integral and derivative presented in the algorithm’s equation. 
∫ ++=
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An example of the code to implement in computer the algorithm is presented 
next: 
previous_error=0;  // 1st cycle 
setpoint=90;   // ideal SpO2  
dt=1/frequency;   
Integral=0; 
 
// define previously the PID coefficients (Kp, Ki e Kd) and the frequency 
while (1)    
{ 
  (……..)       //Reception of SpO2 
error = setpoint – SpO2_mensured; 
 
//Calculation of P, I and D terms 
 
Proportional = Kp*error; 
Derivative = Kd* (error – previous_error) /dt; 
Integral = Ki* (integral + error*dt); 
Output = Proportional + Integral + Derivative;  //Output of the controller 
previous_error = error;     // Error to the next cycle 
}          
  
As can be seen by the code to the computer implementation of the controller, it 
involves the continuous reception of the saturation and therefore the calculation of the 
error between the input oxygen saturation and the defined setpoint, as well as the 
obtaining of the proportional, integral and derivative terms.  
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6.2.1. PID Parameters  
 
This algorithm had already been tested in healthcare applications with the same 
goal as in this project, although not in home care, but in mechanical ventilators and 
neonatal units’ ventilation. Furthermore, in literature there are indicated many 
approaches to coefficients (Kp, Ki and Kd), obtained using several empiric methods that 
provide adequate control. Some of these parameters are presented in the next table: 
 
Author Kp Ki Kd 
Franklin, 1986 1.000 0.100 2.500 
Morozoff, 1994 1.750 0.164 0.1094 
 
Table 8: PID gains obtained by Franklin and Morozoff to accurately control the SpO2. [53] 
 
These coefficients were tested in a computer simulation with MatLab® using the 
code presented above, but none of them are adequate to the system. Consequently, 
the parameters didn’t lead to good results, or even satisfactory, in the output flow’s 
calculation. The procedure used was, with an input value of oxygen saturation and with 
a setpoint of 90%, calculate the error and the output flow. With those parameters, the 
output flows obtained showed to be too large and inappropriate to the model. However, 
the computer simulation only considered the flow’s determination in consideration of 
the SpO2 readings.  
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6.2.2. Analytic Calculation of the PID Coefficients 
 
As the PID gains from the literature weren’t adequate and they’re also 
suggested for other controlling situations, it was analytically calculated the PID 
parameters using the Ziegler-Nichols step response method.  
The analytic calculation of the parameters was based on a curve of patient’s 
open-loop step response from the article, “Oximetry Feedback Flow Control Simulation 
for Oxygen Therapy”, referred in the State of the Art. Although the article doesn’t 
mention the values of the PID parameters used in the computer simulation, it has the 
representative open loop step response due to a step input of oxygen, which is 
presented next: 
  
Figure 52: Representative input step response, for a step change in the oxygen flow rate. [2] 
 
The article only refers two time parameters, which are the time from onset until 
a measurable change in saturation, the dead time (T1), and the lag time (T2) is the time 
between the first measurable change and the final stable measurement. Based on 
literature, the authors considered that T1 and T2 are approximately 6 and 15 s, 
respectively, although these values certainly contain variability between patients and 
are influenced by numerous aspects. [2] 
However, the student faced several problems to calculate the PID parameters, 
since the patient’s mathematical model is unknown, as well as other fundamental 
parameters; besides the curve of the flow rate step response isn’t the best 
representation, which doesn’t enable the closely application of the Ziegler-Nichols’s 
step response method. Nevertheless, using the time constants given by the article and 
through the application of the equations 11 [65], we have: 
Considering two points of non-zero response (t, SpO2): (6, 0), (21, 1), to draw 
the response curve: 
 
    
 
 
67 
Slope of curve:
15
1
216
10
10
10
=⇔
−
−
=⇒
−
−
= RR
tt
yy
R  
 
Sampling time: sTsL s 8.16 =⇒=  
 
Proportional Gain: 3077.2
)8.16(
15
1
2.1
=⇔
+
= PP KK  
Integral Gain: 3403.0
)
2
8.16(
15
1
8.1*6.0
2
=⇔
+
= ii KK  
 
Derivative Gain:
5
8.1*
15
1
6.0
1667.4
8.1*
15
1
5.0
=⇔=
=⇔=
DD
DD
KK
KK
 
 
 Those gains were also tested in a computer simulation with MatLab® using the 
same code and the same procedure, but they didn’t lead to good results. The output 
flows obtained were also too large and inadequate to LTOT patients. 
The output flow values calculated were always compared with the values 
obtained by the empirical considerations, which were used in the construction of the 
algorithm. 
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6.3. Patient’s Data Collecting 
 
Seeing that there wasn’t obtained good results with the analytic calculation of 
the PID parameters, it was used a new approach to obtain them. There was collected 
data, to different values of oxygen flow it was registered the correspondent SpO2 and 
also the times, from patients at the Urgency Service, in CHC. There wasn’t collected 
information from the patients of the Pneumology Service since they are already 
stabilized and their oxygen blood saturation takes much longer to react to oxygen flow 
fluctuations. Consequently, there were monitored three patients suffering from different 
pathologies: two men and a woman that were receiving additional oxygen. 
The patient 1 was a man with 85 years old with chronic lung edema, who had 
severe desaturation due to his congested alveoli. The patient 2 was also a man, with 
79 years old, with diabetes and obesity. The patient 3 was a woman with 58 years old, 
suffering from a neoplasia. Although she had acceptable levels of blood oxygen 
saturation when she was awake, during the sleep she suffered from desaturations and 
she also had fever, which also caused her saturation’s falls. For those reasons, she 
was receiving oxygen supply. 
The oxygen was delivered trough nasal cannulae and the oxygen source used 
was the ramp medical oxygen from the hospital, which has a flow knob to regulate the 
quantity delivered. Additionally, the patients SpO2 measurements were made with each 
patient pulse oximeter.  
The procedure used was the follow: at first, to each patient was cut the oxygen 
delivery, defining a baseline of 0 lpm and the respective SpO2. After that, when the 
SpO2 stabilized, the flow was incremented to 1 lpm. It was then registered the oxygen’s 
saturation and times to each oxygen’s flow, which was varied from 0 to 5-6 lpm. The 
patient 1, which had severe desaturation was the one with the higher flow rate 
delivered (from 0 to 6 lpm), the patient 2 hadn’t show great variations among the 
variations of the oxygen flow, so the flow was varied only from 0 to 4 lpm. The patient 3 
had the higher baseline to 0 lpm and her oxygen blood saturation became stable only 
with 1 lpm of flow.  
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6.3.1. Results 
 
Since each patient suffered from a different pathology, the data obtained has 
huge variance among each other. Furthermore, the curves obtained aren’t according to 
the expected curve and the deviations between each patient are huge, as well, even 
the same patient has large variations with different flow rates. Nevertheless, the patient 
3 became stable with 1 lpm of flow and her response curve is approximated to an “S”, 
which is the expected variation in oxygen’s saturation due to flow’s deviation. So, she 
was chose to the calculation of the parameters. However, in the attachments is 
presented the collected information from the two other patients (patients 1 and 2), as 
well as the graphics with their SpO2 responses due to flow’s fluctuations. The data from 
the patient 3 is presented in the next table: 
 
1 lpm 
Time (min) SpO2 
0 0.92 
4/60 0.92 
25/60 0.93 
34/60 0.94 
39/60 0.95 
46/60 0.96 
1.01 0.96 
1.07 0.97 
1.18 0.97 
1.30 0.98 
2.02 0.98 
2.20 0.99 
2.30 0.98 
2.55 0.98 
3.10 0.99 
3.27 0.98 
3.34 0.98 
3.39 0.99 
3.50 0.99 
3.56 0.98 
4.01 0.98 
4.10 0.99 
4.18 0.98 
4.25 0.97 
4.30 0.98 
4.36 0.98 
4.42 0.99 
4.47 0.99 
4.58 0.99 
5.03 0.98 
5.09 0.98 
5.14 0.99 
5.20 0.99 
5.26 0.99 
5.33 0.99 
5.39 0.99 
5.50 0.99 
6.10 0.99 
6.20 0.98 
6.27 0.98 
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6.33 0.99 
6.45 0.99 
6.59 0.99 
7.04 0.99 
7.15 0.99 
7.30 0.99 
7.50 0.99 
8 0.99 
8.26 0.98 
8.34 0.98 
8.39 0.99 
8.44 0.99 
8.52 0.99 
9 0.99 
9.20 0.99 
9.28 0.99 
9.38 0.99 
9.47 0.99 
10 0.99 
 
Table 9: Patient 3 data collected at the Urgency Service, with the blood oxygen saturation variations and 
correspondents times with a flow rate of 1lpm. 
 
With these data it was obtained the graphic that represents the variation of the 
oxygen saturation with an oxygen flow of 1 lpm. As can be view, the curve obtained 
isn’t exactly the step response in “S”, although it can be approach to it. The dotted line 
represents a simple approach of the curve to an open loop step response of a first 
order system. 
 
Graphic 3: SpO2 variations from patient 3, obtained by varying the flow from 0 to 1 lpm. The red line 
represents the patient response to the flow variation, while the blue dotted line is a simple approach of the 
curve to an open loop step response of a first order system. 
 
 
Variation of the SpO2 wtih an oxygen flow of 1 lpm
0,91
0,92
0,93
0,94
0,95
0,96
0,97
0,98
0,99
1
0 1 2 3 4 5 6 7 8 9 10
Time (min)
Sp
O
2
    
 
 
71 
6.3.2. Data Analysis and Calculation of the PID Parameters  
 
From the graphic and the table with the information, the dead time is L=25 s, 
since the SpO2 of the patient took 25 s to increase from 92% to 93%. After 5.14 min, 
the SpO2 tended to stabilized in 99%, the final stable measurement, although there 
have occurred a few oscillations to 98%. As well, the patient’s SpO2 took much longer 
to stabilize than the expected, since in the referred article, the time between the first 
measurable change and the final stable measurement is 15 s. Consequently, it will 
severely influence the calculation of the gains.   
Sampling time: sTsL s 5.725 =⇒=  
 
Considering two points of non-zero response (t, SpO2): (4, 0.92), (308.4, 0.99) 
Slope of curve: 0003.0
4.3084
99.092.0
10
10
=⇔
−
−
=⇒
−
−
= RR
tt
yy
R  
 
Proportional Gain: 077.123)5.725(0003.0
2.1
=⇔
+
= PP KK  
 
Integral Gain: 491.60
)
2
5.725(0003.0
25*6.0
2
=⇔
+
= ii KK  
 
Derivative Gain:
667.266
5.7*0003.0
6.0
222.222
5.7*0003.0
5.0
=⇔=
=⇔=
DD
DD
KK
KK
 
 
 Those PID parameters are much higher than the gains suggested in literature 
(see table 8) and, as expected, they aren’t satisfactory to apply in the model and there 
weren’t good results when simulated in Matlab.  
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6.3.3. Conclusions 
 
One of the major challenges in SpO2’s precise control is the large unknown 
parameters of the model, as well as the time delays and constants, which differ for 
each patient. Due to this variability, the model robustly can be seriously affected. With 
the data collected it has verified that each pathology lead the patients to different 
responses to the oxygen. Additionally, the SpO2 had been measured using different 
pulse oximeters. Thus, different equipments have different sensors, as well as different 
calibrations, leading to changes in the results between each patient. 
Therefore, although it had been obtained the PID parameters, they do not lead 
to good results in PID computer implementation to control the flow. Additionally, the 
time constants obtained differ from the expected and also the curve used to calculate 
the parameters doesn’t exactly match with an open loop step response of a first order 
system, which also introduced errors in the parameters’ calculation. 
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7. Prototype’s Tests 
 
7.1. Plan of Tests 
 
The prototype was tested in three different stages as the control algorithm was 
developed and optimized.  
The first stage of tests was made with the software Terminal and a red LED to 
simulate the oximeter’s data and the valve’s opening, respectively. Since the PIC 
doesn’t vary the output voltage analogically, there was used a LED to do the tests. It 
was placed on the output compare pin to be actuated by the PWM’s signal and 
Terminal transmitted information from the PC to the PIC that received it via UART1 
(U1RX pin). Furthermore, it was used an oscilloscope to observe the square wave’s 
width varying with the received information.  
 
The second stage consisted in computer simulations that were made already 
with the oximeter and the valve, but without the oxygen source. With the real saturation 
data, it was observed the registers in MPLAB® that indicated the saturation’s readings, 
the correspondents flow and voltage to be applied in the valve.  
 
The last stage of tests was done at the Pneumology Service from CHC and in 
real situations; this stage had two phases.  
 
In the first phase, the tests were made with a COPD patient that usually do 
home oxygen therapy. The patient putted the oximeter sensor in his finger and the 
prototype was connected to the oxygen lines.  
It was verified the receiving and delivering of oxygen by the valve’s ports and 
the flow was measured using a hospital’s flowmeter, from Gasin medical company. 
This flowmeter is used by Gasin’s technicians at the patient’s home to support that the 
person is receiving a certain flow in case of doubt. The flowmeter has a sphere inside a 
graduated tube that is elevated with the oxygen’s flow. Therefore, the quantity of 
oxygen supplied is read by the sphere’s position in the scale of the tube, as can be 
seen in the figure below: 
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Figure 53: Flowmeter from Gasin, the sphere inside the tube is elevated with the flow provided; the 
maximum flow read is 8 lpm. 
 
The oxygen source used was the hospital’s ramp, which has a flow regulator 
knob to manually control the output flow rate and it has an adapter to the oxygen lines 
connection. 
 
Figure 54: Oxygen ramp source from the hospital, with the oxygen line connected in its adapter. 
 
The tests were done with a higher flow than needed; typically 4 lpm of inlet flow, 
and the output was regulated by the valve outside diameter. These tests enable the 
detection of the lack of insulation between the valve’s ports and the oxygen lines. 
  
In the second phase, there were made tests in the same conditions, using the 
hospital’s oxygen source and the flowmeter from Gasin, but with a healthy person. 
However, the valve had already the correct adapters in its ports, which allowed the 
insulation and the quick connecting and disconnecting of the tubes. Since the common 
oxygen cannulae have inside diameters larger than 4 mm, the oxygen lines had to be 
customized. As the valve’s adapters are adequate to oxygen lines with 4 mm of inside 
diameter, Gasin provided an oxygen tube with this diameter. Nevertheless, the inside 
diameter of the flowmeter was the same of the previous tests, thus leading to small 
wastages in the outlet port of the valve, although, those wastages were much lesser 
than in the previous tests, as a result of the adapters presence.  
The prototype was tested in different situations; the first test was made with the 
following procedure: the flow was set higher than needed, 2 lpm, and with the oximeter 
readings was established the correct output flow through the variation of the valve’s 
diameter. The second test was made in the absence of the finger and the flow was set 
again higher than needed, 3 lpm. Finally, the last test done was a conjugation of the 
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two previous tests: the flow was set higher than needed, 4 lpm, and with the oximeter’s 
readings was established the correct flow; then it was absent the finger from the sensor 
to test the system reaction to that absence.  
 
 
Figure 55: Prototype of the system to automatically regulate the output flow; the valve has connected to 
its inlet port the oxygen line customized with 4 mm of inside diameter and the outlet port has attached the 
Gasin’s flowmeter. 
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7.2. Results and Discussion 
 
In the first stage tests, it was confirmed that the LED’s brightness changes with 
different data sent; when the saturation sent was higher the LED’s brightness was 
lower, while when it was lesser the brightness was higher. That is consistent with the 
expected results, since with higher oxygen saturation is need less oxygen, so the valve 
needs to be less open and the applied voltage is therefore lesser, with a low duty cycle 
percentage, as the width of the pulse is lesser. When the oxygen’s saturation falls, the 
valve needs to be more opened, so the applied voltage is higher due to a higher duty 
cycle percentage and the higher wave’s width. The results obtained can be visualized 
with the follow graphic: 
 
 
Figure 56: Wave's duty cycle variation tested with a LED, as the wave's duty cycle changes, the LED’s 
brightness changes, because higher widths of the wave are associated with higher voltages, so the LED’s 
brightness is higher, while with lower widths, the brightness is lesser. 
 
The PWM signal has a variable duty cycle percentage because of the 
changeable width of the pulse and the square waves with different duty cycles (50%, 
25%, 90%,…) were visualize with the oscilloscope. 
 
In the second stage of tests, with the real saturation data, it was observed the 
registers in MPLAB® and they indicated the saturation readings from the oximeter, the 
correct output flow and also the correspondent voltage to be applied in the valve. The 
results were also consistent with the expected theoretically, since it could be confirmed 
that the output voltage was according to the required flow, by means of the valve’s 
calibration curve. 
In the first phase of tests at the Pneumology Service, although the valve 
received and delivered oxygen, the flowmeter wasn’t adjust to the valve’s port as well 
as the oxygen cannula, and there were several oxygen’s wastages in the oxygen pipes 
due to the lack of insulation. So, it couldn’t be measured the oxygen in the outlet port of 
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the valve and there wasn’t a well known quantity of oxygen in the inlet port. Thus lead 
to the system’s improvement with the integration of the correct valve’s adapters. 
 
In the second phase of tests at the Pneumology Service the results obtained 
were also positive. In the first test, the flow was set higher than needed, 2 lpm, and the 
person had 97% of SpO2, whose correct flow would be 0.5 lpm. The valve regulated 
the output dose and it was confirmed with the flowmeter that the real output flow rate 
was actually 0.5 lpm. Therefore, with the developed firmware solution, the flow was 
regulated as it intended to be. 
 In the second test, the flow was set again higher than needed, 3 lpm, and 
without the finger in the sensor, the system set the flow in 2 lpm, as expect.  
In the last test, the flow was higher than needed, 4 lpm, and with the oximeter’s 
readings of a healthy person it was established the correct output flow, which was 0.5 
lpm. Then, it was absent the finger from the sensor. The system promptly react to that 
absence and not only the LED has lighted, but also the flow was set higher, from 0.5 
lpm to 2 lpm.  
The lack of insulation between the outlet port and the flowmeter is because of 
the flowmeter’s tube inside diameter; the tube is not fully connected to the adapter, it is 
adapted to the larger tubes. The flowmeter should also have an inside diameter of 4 
mm in its line to be according to the adapter’s size, however the common oxygen 
cannulae have inside diameters of 6 mm, the flowmeter is custom-made to them. So, 
when the input flow was 2 lpm in the absence of the finger, the output flow should also 
be 2 lpm. However, due to these small losses in the connection of the flowmeter, the 
reading was not 2 lpm, but slightly lower. Thus, taking into account the existence of 
some deviations, the results are in line with the expectations. In fact, the measurement 
of the flow isn’t entirely accurate, being affected not only by the losses in the 
connecting, but also by the reading of the user, given that the sphere position on the 
graduated scale isn’t unique, the readings can be affected by it.  
Those results are according to the wished-for the clinicians and they are also in 
concordance with the project’s goals. 
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Figure 57: Prototype, with the flowmeter connected in the valve’s outlet port and the oxygen line in the 
inlet port, attached to the ramp source, during the tests at the Pneumology Service, CHC. 
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8. Future Works 
Future works will certainly pass to incorporate the accelerometer to register the 
daily physical activity of the patient and correlate it with the oxygen desaturations. To 
the first stage, where the accelerometry data will only be recorded, it will be necessary 
to use the memory of the PIC, which was not addressed in this project. With the 
collected data, it will be necessary to optimize the algorithm’s response to each 
patient’s therapy.  
It also must be implemented an oxygen conserving technique to delivery 
oxygen only during the inhalation or even only during its early stage, when oxygen is 
more valuable. The oxygen saving is one of the system’s goal and to achieve it, the 
system must have a conservation technique implemented, with the patient’s respiratory 
cycle preview.  
The algorithm developed can also be improved and the implementation of a PID 
controller would be the ideal in a system like this, since it would lead to a more 
accurate control. So, the re-calculation of the PID parameters or even a new data 
collection on patients in a controlled laboratory environment would be the desirable 
option. 
The Leonardo Platform isn’t the ideal solution to this system, since there were 
several problems with the reception of the oximeter’s data, which was solved using an 
iDemo board. This isn’t the best to the system’s portability, so in the future the 
Leonardo Platform can be replaced by other board more appropriated and designed 
according to the system’s features and requirements.  
The system can be developed to become portable, through the application of 
batteries in the Leonardo Platform. The Platform has this ability and the battery will 
supply not only the Platform, but also the driver board, the oximeter and the 
accelerometer. That is perfectly possible, since the device’s components are low 
powered, as well, to convert the system in a portable device, it should be taken in 
account the apparatus consumptions to extend the batteries duration.  
As the proportional valve is normally-closed type, as a matter of security, the 
system should also have another valve, parallel to the proportional valve, to be opened 
manually if the electrical current or the battery fails. That would assure the continuous 
supply of oxygen and a system such as a tap would be enough. 
The prototype should also be tested in several circumstances; not only in static 
conditions with the patient sited, but also in dynamic conditions, with the patient moving 
or even running in a crosswalk. 
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9. Conclusion 
 
Oxygen therapy using a proportional valve will control more accurately the 
oxygen flow rate to the patient; the valve can be precisely controlled using the patient’s 
data in an easy and non-invasive way. The dynamic control of the oxygen delivery will 
certainly improve the patient’s life quality. The control based on patient own data 
enables the flow to exactly match the demands that represents a huge step in the 
LTOT. 
The system showed to have fast response to oxygen desaturations, 
immediately giving the correspondent flow and applying the correct voltage to the driver 
board. The rapid response is especially important in dynamic conditions, such as 
movement, where the patient’s blood oxygenation levels fall abruptly.  
The purpose of saving oxygen was partly achieved, because in cases where the 
blood oxygen saturation figures above 90%, the rate of oxygen was gradually 
decreased. Thus, there are substantial savings compared to the continuous and 
constant flow of 2 lpm, typically used in home-based treatments. 
In addition, the use of adapters in the valve’s ports increases the system’s 
safety. As well, the system’s security is assured by other features; if the patient doesn’t 
have the oximeter correctly positioned in the finger, the device will also continue to 
supply oxygen in a continuous way, 2 lpm, which will certainly assure the correct levels 
of the SpO2. Also, the panic button can be pressed in any emergency case.    
The clinical foundations of the controller algorithm will certainly enable the 
patient to spend more time in safe levels of SpO2, slowing the progress of the disease, 
as well as extending the tank’s duration. 
However, besides the positive results, the system needs to be improved in 
order to assure the patient safety, comfort and life’s quality. Nevertheless, the majority 
of the project’s goals were achieved and there were also solved the several problems 
that the system faced during its implementation.   
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PCB’s of the Leonardo Platform 
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Patients’ data collected at the Urgency Service 
 
• Patient with chronic lung edema (Male, 85 years) 
Table 10: Data from a patient with chronic lung edema, the SpO2 variations with oxygen flows from 1 to 
6 lpm. 
1 lpm 2 lpm 3 lpm 4 lpm 5 lpm 6 lpm 
Time 
(min) 
SpO2 Time 
(min) 
SpO2 Time 
(min) 
SpO2 Time 
(min) 
SpO2 Time 
(min) 
SpO2 Time 
(min) 
SpO2 
0 0.76 0 0.70 0 0.76 0 0.80 0 0.84 0 0.85 
9/60 0.63 1/60 0.73 2/60 0.76 1/60 0.80 1/60 0.84 1/60 0.85 
26/60 0.74 21/60 0.72 12/60 0.76 13/60 0.80 17/60 0.83 31/60 0.86 
45/60 0.75 25/60 0.73 32/60 0.76 22/60 0.81 28/60 0.84 38/60 0.86 
50/60 0.75 31/60 0.74 40/60 0.77 28/60 0.81 1.05 0.84 44/60 0.86 
58/60 0.77 36/60 0.74 49/60 0.77 38/60 0.80 1.19 0.84 1.07 0.86 
1.02 0.76 47/60 0.74 51/60 0.78 43/60 0.79 1.30 0.84 1.13 0.85 
1.10 0.81 1.01 0.74 1.12 0.78 47/60 0.80 1.43 0.83 1.19 0.85 
1.15 0.81 1.12 0.73 1.24 0.77 53/60 0.80 1.51 0.84 1.25 0.85 
1.25 0.82 1.22 0.72 1.29 0.78 57/60 0.80 1.57 0.85 1.32 0.86 
1.40 0.82 1.27 0.73 1.43 0.78 1.01 0.79 2 0.84 1.40 0.86 
1.46 0.82 1.33 0.74 1.58 0.79 1.10 0.81 2.16 0.84 1.44 0.84 
1.50 0.83 1.39 0.75 2.03 0.79 1.16 0.82 2.23 0.85 1.50 0.84 
1.56 0.82 1.43 0.79 2.11 0.79 1.22 0.80 2.32 0.85 1.56 0.84 
2 0.80 1.58 0.75 2.20 0.80 1.27 0.79 2.40 0.85 2 0.84 
2.03 0.79 2.03 0.77 2.25 0.80 1.35 0.80 2.58 0.84 2.20 0.85 
2.13 0.77 2.09 0.77 2.39 0.79 1.42 0.80 3.05 0.85 2.25 0.85 
2.17 0.70 2.25 0.78 2.44 0.78 1.49 0.80 3.17 0.84 2.30 0.86 
2.32 0.74 2.29 0.82 2.50 0.79 1.54 0.81 3.30 0.84 2.35 0.86 
2.40 0.74 2.33 0.82 2.55 0.80 2.01 0.81 4 0.84 2.40 0.86 
2.50 0.74 2.37 0.78 3.03 0.80 2.22 0.82 4.10 0.85 2.50 0.85 
2.57 0.66 2.43 0.76 3.09 0.79 2.29 0.83 4.12 0.84 3 0.85 
3.10 0.71 2.46 0.76 3.14 0.80 2.30 0.82 4.22 0.84 3.15 0.85 
3.25 0.70 2.54 0.76 3.20 0.80 2.40 0.82 4.30 0.85 4 0.85 
3.42 0.70 3.02 0.76 3.34 0.81 2.54 0.83 4.41 0.86 4.06 0.84 
4 0.70 3.13 0.75 3.43 0.80 3 0.83 4.47 0.86 4.10 0.84 
3.33 0.75 3.55 0.81 3.14 0.84 4.54 0.85 4.31 0.84 
3.40 0.75 3.59 0.80 3.18 0.84 4.58 0.84 4.36 0.85 
3.52 0.76 4.08 0.80 3.21 0.85 5.02 0.85 4.45 0.87 
4.04 0.76 4.20 0.80 3.26 0.84 5.10 0.84 4.50 0.87 
4.08 0.75 4.37 0.80 3.30 0.83 5.21 0.83 4.53 0.88 
4.23 0.76 4.49 0.80 3.38 0.84 5.29 0.85 4.58 0.88 
4.28 0.76 5 0.80 3.49 0.83 5.34 0.85 5.03 0.86 
4.35 0.75 5.11 0.81 3.54 0.84 5.38 0.85 5.06 0.87 
4.41 0.76 5.25 0.80 3.58 0.84 5.43 0.84 5.10 0.86 
4.49 0.77 5.30 0.80 4.04 0.84 5.46 0.84 5.46 0.86 
4.56 0.77 5.40 0.81 4.16 0.83 5.51 0.85 5.56 0.85 
5 0.77 5.47 0.80 4.30 0.83 6.02 0.85 6.15 0.86 
5.12 0.76 5.58 0.80 4.50 0.84 6.08 0.85 6.20 0.85 
5.20 0.76 6 0.80 5 0.84 6.20 0.85 6.30 0.85 
 
 
6 0.76 
 
6.30 0.86 6.40 0.84 
6.42 0.85 6.44 0.81 
7 0.85 6.46 0.80 
6.57 0.82 
6.7 0.82 
7.06 0.82 
7.10 0.83 
7.25 0.83 
7.31 0.85 
7.41 0.86 
 
7.50 0.86 
8 0.86 
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SpO2 variations with 1 lpm of flow
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Graphic 4: SpO2 variations from patient 1, with 1 lpm of oxygen flow. 
 
  
SpO2 variations with 2 lpm of flow
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Graphic 5: SpO2 variations from patient 1, with 2 lpm of oxygen flow. 
 
 
SpO2 variations with 3 lpm of flow
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Graphic 6: SpO2 variations from patient 1, with 3 lpm of oxygen flow. 
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SpO2 variation with 4 lpm of flow
0,78
0,79
0,8
0,81
0,82
0,83
0,84
0,85
0,86
0 0,5 1 1,5 2 2,5 3 3,5 4 4,5 5
Time (min)
Sp
O2
 
Graphic 7: SpO2 variations from patient 1, with 4 lpm of oxygen flow. 
 
 
SpO2 variations with 5 lpm of flow
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Graphic 8: SpO2 variations from patient 1, with 5 lpm of oxygen flow. 
 
 
 
SpO2 variations with 6 lpm of flow
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Graphic 9: SpO2 variations from patient 1, with 6 lpm of oxygen flow. 
 
 
 
    
 
 
100 
• Patient with diabetes and obesity (Male, 79 years) 
 
 
1 lpm 2 lpm 3 lpm 4 lpm 
Time (min) SpO2 Time (min) SpO2 Time (min) SpO2 Time (min) SpO2 
0 0.86 0 0.87 0 0.87 0 0.88 
20/60 0.86 13/60 0.87 7/60 0.88 11/60 0.88 
34/60 0.87 43/60 0.87 12/60 0.88 24/60 0.89 
50/60 0.87 48/60 0.86 26/60 0.88 32/60 0.89 
1 0.87 54/60 0.87 36/60 0.87 46/60 0.89 
1.3 0.87 1 0.89 41/60 0.90 1 0.89 
1.4 0.87 1.05 0.90 44/60 0.91 1.18 0.89 
1.54 0.88 1.11 0.88 54/60 0.90 1.25 0.89 
2 0.88 1.16 0.87 58/60 0.89 1.30 0.89 
2.28 0.86 1.24 0.87 1.07 0.88 1.46 0.89 
2.4 0.86 1.30 0.87 1.14 0.88 1.55 0.89 
2.5 0.86 1.37 0.86 1.28 0.88 2 0.89 
2.6 0.86 1.48 0.87 1.37 0.88 2.05 0.88 
3 0.86 1.57 0.86 1.45 0.88 2.15 0.88 
3.1 0.86 2.05 0.87 1.51 0.88 2.26 0.88 
3.2 0.86 2.22 0.87 2 0.88 2.40 0.88 
3.5 0.86 2.39 0.87 2.15 0.88 3 0.88 
3.9 0.86 2.54 0.86 2.23 0.88 3.19 0.88 
4 0.87 2.58 0.86 2.38 0.88 3.24 0.89 
4.15 0.87 3.04 0.87 2.41 0.89 3.36 0.89 
4.32 0.88 3.10 0.88 2.48 0.89 3.54 0.89 
4.46 0.88 3.16 0.87 2.54 0.89 3.57 0.90 
4.54 0.89 3.28 0.87 2.57 0.90 4.04 0.91 
5.11 0.87 3.33 0.86 3.03 0.90 4.09 0.90 
5.19 0.88 3.37 0.87 3.07 0.89 4.16 0.89 
5.32 0.89 3.51 0.87 3.13 0.89 4.25 0.88 
5.46 0.88 3.57 0.87 3.21 0.89 4.30 0.89 
6 0.87 4.04 0.87 3.25 0.88 4.48 0.89 
6.20 0.87 4.13 0.86 3.31 0.88 5 0.89 
6.37 0.88 4.18 0.86 3.39 0.88 5.10 0.89 
6.50 0.87 4.25 0.87 3.44 0.89 5.20 0.88 
7 0.90 4.29 0.87 3.51 0.89 5.27 0.88 
7.15 0.88 4.40 0.87 3.56 0.89 5.38 0.88 
7.23 0.87 4.47 0.86 4.02 0.88 5.50 0.88 
7.35 0.87 4.55 0.87 4.13 0.88 6 0.88 
7.50 0.87 5 0.87 4.20 0.89 6.14 0.89 
8.07 0.88 5.15 0.87 4.25 0.89 6.28 0.89 
8.13 0.88 5.30 0.86 4.30 0.90 6.40 0.89 
8.23 0.87 5.40 0.86 4.35 0.90 6.53 0.89 
8.35 0.87 5.42 0.87 4.41 0.91 7.03 0.89 
8.46 0.86 5.50 0.87 4.46 0.92 7.07 0.88 
8.52 0.88 6 0.87 4.51 0.92 7.17 0.88 
9 0.89 6.08 0.87 4.53 0.91 7.29 0.88 
9.14 0.87 6.14 0.86 4.57 0.91 7.35 0.88 
9.23 0.87 6.20 0.88 5.02 0.90 7.56 0.88 
9.30 0.87 6.28 0.89 5.07 0.90 8 0.88 
9.42 0.86 6.38 0.88 5.10 0.89 8.21 0.88 
9.46 0.87 6.47 0.87 5.17 0.89 8.27 0.89 
9.57 0.87 6.56 0.87 5.29 0.89 8.31 0.87 
10 0.87 7.03 0.88 5.38 0.89 8.41 0.87 
7.06 0.90 5.50 0.89 8.49 0.86 
7.11 0.92 5.57 0.88 8.59 0.86 
7.15 0.91 6 0.88 9 0.85 
7.19 0.90 6.07 0.89 9.11 0.85 
7.24 0.90 6.14 0.89 9.17 0.87 
7.29 0.90 6.25 0.89 9.22 0.90 
7.36 0.89 6.52 0.89 9.27 0.91 
7.42 0.88 7 0.89 9.34 0.91 
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2 lpm (cont.) 3 lpm (cont.) 4 lpm (cont.) 
7.47 0.88 7.03 0.90 9.44 0.90 
7.51 0.88 7.18 0.90 9.54 0.90 
8.11 0.87 7.25 0.89 10 0.90 
8.17 0.87 7.30 0.90 
8.30 0.87 7.37 0.90 
8.39 0.87 7.40 0.90 
8.45 0.88 7.46 0.89 
8.55 0.87 7.50 0.89 
9 0.87 8.04 0.90 
9.16 0.87 8.10 0.91 
9.23 0.87 8.15 0.94 
9.37 0.87 8.24 0.95 
9.41 0.87 8.28 0.94 
9.50 0.89 8.33 0.93 
10 0.88 8.36 0.92 
8.40 0.92 
8.46 0.92 
8.48 0.90 
9 0.89 
9.07 0.89 
9.15 0.88 
9.35 0.88 
9.42 0.88 
9.47 0.89 
9.54 0.88 
10 0.88 
 
 
 
Table 11: Data from a patient with diabetes and obesity, the SpO2 variations to oxygen flows from 1 to 
4 lpm. 
 
 
SpO2 variations with 1 lpm of flow
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Graphic 10: SpO2 variations from patient 2, with 1 lpm of oxygen flow. 
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SpO2 variations with 2 lpm of flow
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Graphic 11: SpO2 variations from patient 2, with 2 lpm of oxygen flow. 
 
 
SpO2 variations with 3 lpm of flow
0,86
0,87
0,88
0,89
0,9
0,91
0,92
0,93
0,94
0,95
0,96
0 1 2 3 4 5 6 7 8 9 10
Time (min)
Sp
O2
 
Graphic 12: SpO2 variations from patient 2, with 3 lpm of oxygen flow. 
 
 
SpO2 variations with 4 lpm of flow
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Graphic 13: SpO2 variations from patient 2, with 4 lpm of oxygen flow. 
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Driver Board Technical Specifications 
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Miniature Proportional Valve Technical Specifications 
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XYZ Plux Accelerometer Technical Specifications 
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OxiLinkTM Pulse Oximeter Technical Specifications 
 
 
